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Introduction and purpose of this study 
Central areolar choroidal dystrophy (CACD) is a hereditary choroidal dystrophy 
of the posterior pole of the eye. The end-stage of this disease is characterized by 
the presence of a well-defined area of atrophy of the photoreceptors, retinal 
pigment epithelium and underlying choriocapillaris in the macular region. In 
CACD a central scotoma may gradually develop over several years in middle-aged 
patients. This generally leads to severe visual impairment, to the level of counting 
fingers. In the majority of cases, this loss of vision will occur before the age of 
sixty. 
Up to the present, only four families have been described in world literature where 
members in more than one generation have been afflicted, and six families where 
several siblings in one generation have been afflicted. On the basis of these reports, 
CACD appears to be either autosomal-dominantly or recessively inherited. In 
addition to these, a number of sporadic cases have been reported. 
Almost all the patients described, were first encountered by the authors only in 
the atrophic end-stage of the disease. Six patients only were encountered with 
fundus alterations preceding the atrophic end-stage. All of the latter consulted an 
ophthalmologist because of visual complaints. 
The natural course of CACD has not been detailed, and very little is in fact 
known about the natural course of the disease, probably due tot the fact that 
subjects are almost asymptomatic until they reach the atrophic end-stage. 
Electrophysiological and psychophysical tests have been performed only in a very 
few cases. 
Despite the fact that there is no effective treatment for CACD, early recognition 
of CACD in young patients without visual complaints can make a significant 
contribution to their later lives. Knowledge of the genetic aspects of CACD is also 
important for the purposes of genetic counselling. Furthermore, as other ocular 
diseases may present similar clinical pictures to that of CACD, differentiation is 
important for diagnostic purposes. 
Since the opportunity to examine seven afflicted families, as well as seven 
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sporadic cases of CACD, occurred, the opportunity was seized to gain and 
systematize more information about this fairly rare disease. Patients with visual 
complaints and macular changes, as well as asymptomatic family members in 
whom macular alterations were detected, were invited to undergo further 
ophthalmic examinations, fluorescein angiography, as well as psychophysiological 
and electrophysiological tests, focusing on the early stages of the disease. 
With the results of these examinations and tests, it has been possible to describe 
the development of CACD from the earliest macular changes to the atrophic end-
stage, to gather more information about the genetic nature of the disease and to 
clearly distinguish CACD from other macular diseases. 
In summary then, the purpose of the study is: 
• to describe the natural course of CACD with particular emphasis on early 
fundus changes; 
• to contribute to the analysis of the genetics of CACD; 
• to set criteria for the differentiation of CACD from other diseases of the 
posterior pole of the eye. 
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CHAPTER 1 
R E V I E W OF T H E L I T E R A T U R E 
1.1 Central areolar choroidal dystrophy 
1.1.1 Case reports 
In 1884 Nettleship reported the case of a sixty-year-old woman with a large area 
of atrophy of retinal pigment epithelium and choriocapillaris in both fundi. The 
patient's vision had been 'fading away' over a period of twelve years. Nettleship 
called his discovery 'central senile areolar choroidal atrophy' and wondered 
whether the increased visibility of the larger choroidal vessels could be ascribed to 
sclerosis of these vessels. After this publication, there were several reports of 
individual cases. Jaeger (1855) reported the case of a woman aged sixty, Retze 
(1902) of a man aged sixty-six, and Thompson (1905) of a woman of sixty-three 
years. No incidence in families was described at that time. 
In 1931, at the annual meeting of the Dutch Ophthalmologic Society, De Haas 
reported the case of a family with a 'hereditary degeneration of the macula lutea'. 
He had found round areas of atrophy of pigment epithelium and choriocapillaris in 
the centre of the macula in an eighty-year-old father and his three sons, aged 
respectively forty-eight, fifty-one and fifty-three. The patients had experienced 
impaired vision from their early forties onwards. De Haas thought that a nutritional 
disorder might have caused the disease. This was the first report of autosomal-
dominant heredity in CACD. 
Sorsby (1935) was the first to describe the genetic nature of the condition. He 
reported its occurrence in two brothers, aged fifty-nine and sixty-three years 
respectively. No other family members were affected. In 1953, Sorsby and Crick 
reported on two sisters out of a sibship of nine, four sisters and one brother out of a 
sibship of seven, two sisters and one brother out of a sibship of six and an affected 
mother and daughter. He thought that the choroidal vessels were sclerotic in the 
end-stage and proposed to call the disorder a 'central areolar choroidal sclerosis'. 
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Ashton (1953) described pathology findings in one of the cases noted earlier: he 
found no sclerosis of the choroidal vessels. The first dominant trait of CACD was 
reported by Sandvig in 1955, citing thirteen cases over four generations. The onset 
of visual disturbances in these patients varied from the ages of twenty to thirty 
years (Sandvig, 1955). 
Four years later, in 1959, Sandvig published the case of four patients with 
CACD, of whom two were sisters. She found a reduced dark adaptation in these 
patients and suggested that the peripheral retina may also be affected. In 1965, Can-
reported the case of a mother and two daughters, all of whom had experienced 
symptoms from their early teens. He also cited reduced responses in the electro-
retinogram (Carr, 1965a). 
Deutman (1971) described five cases, in three of which he had performed 
fluorescein angiography. He found one patient with slight parafoveal 
depigmentation. 
In 1975 Carr et al. added five more cases to the three they had described earlier 
(Carr, 1975). Carr concluded that the choriocapillaris may well be the primary 
affected layer. 
Noble (1977) gave a detailed description of the fluorescein angiographic 
findings in a new case and in a patient formerly described by Carr (1965a), and 
found atrophy of the choriocapillaris in late, as well as in the earlier stages. In the 
same year he published a report on a father and his affected son and daughter, aged 
respectively fourteen and twelve, both of whom showed granular 
hyperfluorescence in the macula. 
Hutter and Marquardt (1989) examined a mother and her two sons from a 
family in which five other members over three generations were probably also 
affected. In this family he found one patient with atrophy of the pigment epithelium 
and two with additional atrophy of the choriocapillaris. 
1.1.2 Early cases 
A few cases of young patients with small changes in the fundus have been 
described. Sorsby and Crick (1953) presented the case of a thirty-year-old woman 
from a family with an autosomal-dominant trait of CACD. Fundus photography 
showed an area of pigmentary mottling around the fovea. 
Sandvig (1955) reported on a twenty-eight-year-old man belonging to a family 
with an autosomal-dominant trait of CACD. Visual acuity was 0.6 in both eyes. 
Photographs of the fundi again showed an area of pigmentary mottling around the 
fovea. 
15 
CHAPTER I 
Carr (1965a) described two daughters of a mother who suffered from an 
advanced stage of CACD. They were fifteen and twenty-two years old respectively. 
One had visual acuity of 20/70 in the right eye and 20/60 in the left eye, while the 
other had visual acuity of 20/100 in the right eye and 20/100 in the left eye. In both 
cases the macula showed a diffuse area of granular hyperpigmentation. Both 
patients revealed a central scotoma and suffered from abnormal colour vision. 
Deutman (1971) reported on a twenty-year-old woman from an unaffected 
family. Her visual acuity was 20/20 in both eyes. The fundi showed whitish flecks 
just parafoveally in both eyes. Fluorescein angiography revealed defects of the 
pigment epithelium with some atrophy of the choriocapillaris. 
Carr et al. (1975) described a twenty-five-year-old man with a decreased visual 
acuity of 20/200 in the right eye and 20/400 in the left eye. Fundus photographs 
showed an irregular area of loss of pigment epithelium in the posterior poles of 
both eyes. 
1.1.3 Clinico-pathological findings 
Up to the present five studies dealing with microscopical changes in CACD 
have been published. 
Ashton (1953) examined both eyes of a fifty-six-year-old woman, who had died 
of coronary thrombosis. The patient was a member of a family which had been 
described by Sorsby and Crick (1953). The posterior ciliary arteries were found to 
be normal. Microscopical examination showed that the choriocapillaris was 
completely absent in the affected zone. There was marked choroidal atrophy within 
the affected area, but no atherosclerotic changes could be detected here or 
elsewhere in the choroid. The outer layers of the retina had disappeared without 
glial replacement. Bruch 's membrane was little affected by the failure of choroidal 
blood supply and showed only diffuse thickening and patchy absorption of the 
elastic outer layer. Ashton disagreed with Klien's view (1950), that the choroidal 
changes were simply an extension or severe form of primary macular degeneration. 
Babel (1958) examined the eyes of a seventy-year-old man with CACD. The 
family history of the patient was not recorded. She found numerous drusen 
surrounding an area of atrophy of the retina, pigment epithelium and 
choriocapillaris. Bruch's membrane showed ruptures and a lamellar structure. 
Howard and Wolf (1964) discovered a patchy atrophy of the choriocapillaris, 
retinal pigment epithelium and the outer retinal layers posterior to the equator. The 
inner retinal layers were intact. Bruch's membrane was diminished and fragmented 
in places, but appeared thickened and basophilic in other places. No drusen of 
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Bruch's membrane were seen. The choriocapillaris posterior to the equator became 
sparse and indistinguishable from the surrounding tissue. 
Klien (1964) described the histological changes in the right eye of a seventy-
one-year-old man in whom a diagnosis of CACD had been made. There was no 
family history. The eye had been removed because of secondary glaucoma, 
following a venous occlusion. She spotted a well-defined macular defect of the 
neuro-epithelium, pigment epithelium and choriocapillaris. In the peripheral 
portion of the atrophic area a few scattered lumina of the choroidal capillaries 
could still be detected, while these, as well as medium size vessels, had 
disappeared in the central portion, leaving only a few arteries surrounded by 
fibrous stroma. Sclerosis was not found in these vessels, nor in the posterior ciliary 
arteries. Klien mentioned that these findings resembled those of Ashton (1953) and 
were different from the findings she had described earlier (Klien, 1950) in the 
primary heredo-degeneration of the first neuron, in which no choroidal defects 
were found. 
Ferry et al. (1972) reported on a pathological examination of the left eye of a 
seventy-six-year-old man who had suffered from a progressive loss of vision 'for 
many years'. The eye had been enucleated for absolute glaucoma. There was no 
family history of eye problems. In the macular region he found a well-defined area 
of about two disc-diameters wide in which the outer layers of the retina and the 
pigment epithelium were absent and the choriocapillaris was obliterated. The 
external limiting membrane appeared to adhere to Bruch's membrane in some 
areas, while Bruch's membrane was slightly thickened and exhibited focal areas of 
basophilia. It also showed focal areas of increase of connective tissue in the 
intercapillary zone. The number of medium and larger choroidal vessels seemed to 
be reduced. The larger choroidal vessels showed no sclerotic changes, nor did the 
posterior ciliary arteries. 
1.1.4 Fluorescein angiography 
Novotny and Alvis (1961), Brooser and Uzonyi (1968), and Curry and 
Schonberg (1969) were the first to report on fluorescein angiography findings with 
regard to CACD. Maumenee (1968), and Curry and Schonberg (1969) noted a loss 
of retinal pigment epithelium and choriocapillaris in CACD in the posterior pole 
and a loss of choriocapillaris in the area surrounding the lesion. Hyvarinen et al. 
(1969) described the leakage of dye from the margins of the lesion into the central 
area, where it persisted a long time after its disappearance from the choroid. An 
increased visibility of the intermediate and larger choroidal vessels in the retinal 
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arterial and early venous phase was described by Archer et al. They also observed 
the presence of dye in the choroidal arteries in the late venous phase (Archer et al; 
1971). 
In normal subjects these vessels were empty in the retinal arterial and early 
venous phase (Archer et al., 1970). The perfusion pressures of the choroid in 
affected patients seemed to be normal (Archer et al., 1972). Noble et al. described 
atrophy of the choriocapillaris in an early case of CACD, although the 
choriocapillaris appeared normal in fundus examination (Noble et al., 1977). 
Based on fluorescein angiographic and ophthalmoscopic findings in the later 
stages of the disease, Krill (1977) divided the progress of the disease into four 
stages: 
stage I: normal ophthalmoscopic aspect, but a mottled hyperfluorescence in 
fluorescein angiography; 
stage 2: atrophy and clumping of retinal pigment epithelium; mottled hyper-
fluorescence, similar to stage 1 ; 
stage 3: ophthalmoscopic picture as in stage 2, but atrophy of the choriocapillaris 
makes the larger and intermediate size vessels of the choroid visible in fluorescein 
angiography; 
stage 4: choroidal vessels visible in ophthalmoscopy; obliterated choroidal vessels 
appear as white lines; white deposits and fine pigment can be seen in the 
intervascular spaces; fluorescein angiography shows a striking visibility of the 
larger choroidal vessels. 
1.1.5 Electroretinography (ERG) 
ERG was first done in CACD by Franceschetti et al. (1963a) on a forty-year-old 
man and his fourteen-year-old and eight-year-old daughters. Franceschetti found a 
subnormal scotopic ERG in the father, while the photopic results appeared normal. 
In 1965 Carr reported on a case involving a fifty-seven-year-old mother and her 
twenty-two-year-old and fifteen-year-old daughters. In the mother he found 
reduced photopic and scotopic responses. The initial red and the second red 
responses were reduced. In the two daughters he found a slightly reduced photopic 
response. The scotopic ERG showed no initial red response and a normal second 
red response. Otherwise the scotopic ERG was normal. 
As a result of these findings Carr concluded that in the later stages the disease 
may be more generalized than is apparent ophthalmoscopically (Carr, 1965a). 
However, these results were not confirmed by later publications, in which the ERG 
results in the later stages of the disease proved either normal or slightly subnormal 
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(Krill, 1966; François et al., 1969; Deutman, 1971; Carr et al., 1975; Noble, 1977; 
Zrenner et al., 1986). 
1.1.6 Dark adaptation (DA) 
Several authors reported on measuring dark adaptation in cases of advanced 
CACD. Reduced dark adaptation was described by Sandvig (1959) in four patients 
and by Deutman (1971) in one case. Normal results were noted by Carr (1965a; 
Carr et al., 1975) in three cases, by Deutman (1971) in two cases, and by Zrenner 
(1986) in one case. Deutman (1971) found normal dark adaptation in a patient who 
probably suffered from an early stage of CACD. 
None of the authors mentioned numerical values. 
1.1.7 Electro-oculography (EOG) 
In one of the three familial cases which had been described by Franceschetti, 
electro-oculography was performed. The results were normal. 
Carr (1965a) also found normal readings in one of his patients. 
In 1966 Krill reviewed the ERG and EOG findings in patients with macular 
diseases. He also reported normal ERG and EOG readings in one of his own 
patients with CACD. François (1969) found a pathological EOG in a patient 
suffering from CACD in an advanced stage. In other cases reported thereafter, 
EOG values varied from slightly subnormal to normal (Deutman, 1971; Carr et al., 
1975; Noble, 1977; Zrenner et al., 1986). 
1.1.8 Colour vision 
Colour vision tests (Ishihara plates) were carried out in five of the fourteen 
cases (from five families) described by Sorsby and Crick. Disturbed colour vision 
was detected in four cases and normal results were reported in one of these 
patients. Franceschetti et al. found an achromatopsia with decreased red-sensibility 
in one patient and a combined red-green and blue-yellow defect in another patient. 
In the advanced CACD cases reported by Carr and Noble, erratic responses to 
the HRR-plates were noted and either normal or deutan pattern or confused results 
were achieved in the Farnsworth D-15 panel test (Carr, 1965a; Carr et al., 1975; 
Noble, 1977). In a patient suffering from CACD in an early stage, reported by 
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Noble, a moderate red-green defect was detected by the HRR-plates and normal 
responses were recorded with regard to the Farnsworth D-15 panel tests. 
A tritan axis with an error score of 596 was found in a patient with a paracentral 
scotoma (Zrenner et al., 1986) by means of the Famsworth-Munsell 100-Hue test. 
In the same patient pseudoprotanomaly was also detected by means of the Nagel 
anomaloscope. 
1.1.9 Visual Fields 
Visual fields appear to have been examined in only very few of the patients 
described in literature. Kinetic perimetry was used in all these cases. Carr (1965a) 
found a central scotoma within 15 degrees of the centre in three advanced cases of 
CACD. Noble (1977) noted a central scotoma in one patient. A paracentral 
scotoma was observed by Zrenner et al. (1986) in one patient. Deutman (1971) 
found no abnormalities in the visual fields of a patient who probably suffered from 
CACD in an early stage. 
1.1.10 Central areolar choroidal dystrophy and other diseases 
In 1987 Mansour reported on three brothers - of consanguineous parents - who 
suffered from both CACD and pseudoachondroplastic spondyloepiphyseal 
dysplasia. Deutman (1971) reported the case of a sixty-year-old man who suffered 
from CACD, acute poliomyelitis and acute rheumatism. There are no other reports 
of CACD encountered in association with other diseases. 
1.1.11 Genetics 
In 1935, Sorsby reported the case of two brothers with CACD. He later 
encountered three more families with several affected members in one generation. 
Sorsby considered that autosomal-recessive heredity might be responsible, but 
because he found that more than twenty-five percent of the siblings were affected 
in one generation, he remained slightly uncertain. Krill (1977) pointed out that 
autosomal-recessive heredity was involved in a case reported by Waardenburg et al. 
(1952), referring, however, to a pedigree of peripapillary choroidal atrophy. In 
other reports autosomal-recessive heredity was not confirmed. 
Sandvig (1955) could prove autosomal-dominant heredity in a family with 
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thirteen affected members, because of direct transmission over three generations. 
This was confirmed by a frequency of affected individuals of approximately fifty 
percent and the absence of sex predilection. Hutter and Marquardt (1989) described 
a second family with affected siblings over three generations. Apart from these two 
families there are no reports on families in which the mode of heredity was clearly 
established. 
1.1.12 Summary 
A few families and some sporadic cases of CACD have been described in literature. 
Only four families with affected patients from two or more generations have been 
reported (Sorsby, 1953; Sandvig, 1955; Carr, 1965; Hutter and Marquardt, 1989). 
Autosomal heredity was proven in two of these cases (Sandvig, 1955; Hutter and 
Marquardt, 1989). CACD in several siblings of one generation has been reported in 
six families (Sorsby, 1935; Sorsby and Crick, 1953; Sandvig, 1959; Carr, 1965a). 
Autosomal-recessive heredity was suspected, but could not be proven. 
In most cases, the end-stage of CACD was described as involving a central 
scotoma, a well-demarcated area of atrophy of pigment epithelium and chorio-
capillaris in the posterior pole, and abnormal colour vision. Electrophysiological 
tests in these cases provided normal or subnormal results. Fluorescein angiography 
and pathological studies reveal that the atrophy is confined to the retinal pigment 
epithelium, choriocapillaris and smaller choroidal vessels. 
1.2 Central areolar choroidal dystrophy: related disorders 
1.2.1 Age-related macular degeneration (ARMD) 
Age-related macular degeneration is the leading cause of legal blindness in the 
western world (Kahn and Moorhead, 1973; Leibowitz et al., 1980; Sorsby, 1972). 
Incidence of this disorder can be divided into exudative and non-exudative types. 
The exudative type is characterized by fluid and/or haemorrhage beneath the retinal 
pigment epithelium or neurosensory retina. Choroidal neovascularisation is 
frequently present. The non-exudative type is characterized by hard drusen 
(indicative of localized dysfunction of the retinal pigment epithelium), soft drusen 
(indicative of diffuse dysfunction of the retinal pigment epithelium) and sharply 
defined areas of atrophy of the pigment epithelium within the macula, referred to as 
geographic atrophy (Bressler et al., 1988). Because the geographic atrophy in 
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ARMD may resemble CACD, this aspect of ARMD will be described in more 
detail. 
In five to ten percent of the cases of loss of central vision due to ARMD, it is 
caused by geographic atrophy. The average age of onset is about seventy years. 
Five to ten percent of these patients will progressively lose vision in the second eye 
every year thereafter. Twenty percent of the patients with geographic atrophy in 
one eye will develop choroidal neovascularisation in the second eye (Blair, 1975; 
Sarks and Sarks, 1989; Gass, 1973 & 1987). 
Sarks and Sarks (1989) performed a detailed study of the clinical and 
pathological changes in geographic atrophy. They divided the patterns of evolution 
into three groups: 
1. Primary, age-related atrophy. This is caused by failure of the retinal pigment 
epithelium. Accumulation of lipofuchsin leads to cellular hypertrophy and 
subsequent elimination of spent cells or portions of cells. Basal laminar deposits 
(abnormal basement membrane material) appear between the plasma membrane 
and the basement membrane. 
This process leads to a progressive build-up of debris in Bruch 's membrane and 
sometimes to the formation of hard drusen. Due to an accumulation of debris, the 
Figure I. Right eye of sixty-eight-year-old patient with a geographic atrophy surrounded by several 
hyperfluorescent drusen. 
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pigment epithelium cells enlarge and become increasingly pigmented. Attenuation 
of the retinal pigment epithelium adjacent to clumps or lines of hyperpigmentation 
is a prelude to the development of patches of atrophy which, in fluorescein 
angiography, can be recognized as window defects (Figure 1). Thus, drusen are 
present but do not determine the outcome. The atrophy tends to expand in a horse-
shoe shape, developing simultaneously in several parts of the parafovea. Patients 
can retain good visual acuity for many years. 
2. Drusen-related atrophy. Most cases of geographic atrophy follow on the 
development of drusen. The pattern of atrophy of the pigment epithelium overlying 
the drusen reflects the distribution of the drusen. In most cases these patches of 
atrophy are distributed around the fovea. Later these patches enlarge, precipitating 
the typical picture of geographic atrophy. 
3. Atrophy after collapse of a serous pigment epithelium detachment. This happens 
in particular when the detachment develops after the formation of soft drusen. 
Visual acuity can remain intact for some time, as long as the pigment epithelium 
layer is unaffected. However, after a while the lesion flattens and this is followed 
by atrophy of the overlying pigment epithelium. Geographic atrophy develops 
more rapidly when the serous detachment is complicated by a rupture and 
subsequent retraction of the pigment epithelium. 
Blair (1975) compared one hundred and eighty-four patients with geographic 
atrophy with cases of CACD described in literature and concluded that in 
geographic atrophy the age of onset is much later, that there is less symmetrical 
involvement, that drusen are often prominent, that the atrophy is sometimes 
preceded by a serous detachment of the retinal pigment epithelium and that there is 
no definite autosomal-dominant heredity (although Gass (1972) presented some 
evidence that ARMD can be inherited on an autosomal-dominant basis). 
1.2.2 Stargardt's disease 
In 1909, Stargardt first described a bilateral, hereditary, macular dystrophy 
occurring in seven patients from two families in which visual loss was first noticed 
between the ages of eight and sixteen. Males and females were equally affected and 
though no consanguinity was noted, a recessive heredity seemed likely. Stargardt's 
patients and nearly all cases published since, showed an autosomal-recessive mode 
of heredity. Only a few pedigrees with a possible autosomal-dominant heredity 
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have been reported (Merin and Landau, 1970; Cibis et al., 1980). Recently, genetic 
linkage analysis assigned the disease locus to chromosome 1 p21 -p 13 in autosomal-
recessive cases (Kaplan et al., 1993). In a family with an autosomal-dominant 
inheritance the disease was mapped to chromosome 13q34 (Zhang et al., 1994). 
Franceschetti (Franceschetti, 1963a-b; Franceschetti and François, 1965a) 
introduced the term 'fundus flavimaculatus' to characterize a fundus picture with 
ill-defined yellowish-white spots in the posterior pole. He published a detailed 
description of 30 patients with various manifestations of this disease. Franceschetti 
(1965b) noted atrophic macular lesions in eighteen of thirty-six patients, while 
Klien and Krill (1967) made this observation in eighteen among twenty-seven 
patients. Deutman and Krill noted that the term 'Stargardt's disease' should only be 
used for those patients having fundus flavimaculatus-like lesions with foveal 
dystrophy which, in fact, would include the majority of affected patients. However, 
in late stages of fundus flavimaculatus without macular involvement, atrophic 
foveal lesions can often be found (Deutman, 1989 & 1971; Krill and Deutman, 
1972b). 
Fishman identified four stages in Stargardt's disease, ranging from localized 
central pigment epithelium, photoreceptor, and occasionally choriocapillaris 
disease, to diffuse, totally resorbed flecks and extensive choriocapillaris atrophy 
(Fishman, 1976; Notting and Pinckers, 1978). Histopathological studies showed 
that the clinical and fluorescein angiographic manifestations of this disease were 
consistent with accumulation of a lipofuchsin-like substance and with acid 
mucopolysaccharide in the pigment epithelium cells (Klien and Krill, 1967; Eagle 
et al., 1980). Reexamination of an (autopsy) eye of an infant of sixteen months, 
who had developed Stargardt's disease at the age of nine months, revealed 
increased autofluorescence, increased reactivity to periodic acid-Schiff staining and 
a displacement of melanin granules towards the apex of retinal epithelial cells 
(Steinmetzetal., 1991). 
The terms Stargardt's disease and fundus flavimaculatus are still used 
interchangeably and this can easily lead to confusion. 
In most of the cases cited in literature, bilateral diminution of vision starts 
between the age of six and twenty. Sometimes patients complain of slight 
metamorphopsia or diminished central vision. Often no - or only a slight -
abnormality can be perceived in the posterior pole. Men and women are equally 
affected and there is no racial predilection either (Deutman, 1971; Krill and 
Deutman, 1972b; Noble and Carr, 1979). 
Initially, pigmentary changes in the macula vary from a non-specific pigment 
mottling to a 'beaten-bronze metal' or 'snail-slime' (bave d'escargot) appearance. 
Atrophic macular lesions are surrounded by yellowish-white flecks that are usually 
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two disc-diameters in width and 1,5 disc-diameters in height. Later, new flecks 
appear, forming a broad garland that may include the portion nasal to the optic 
disc. This progression may develop over several years. The flecks confluate and 
after a while resorb, leaving atrophic fundus lesions. The diagnosis of Stargardt's 
disease becomes more and more difficult when secondary choriocapillaris atrophy 
develops, probably due to a decrease in metabolic function in the overlying retina 
and pigment epithelium. In the end-stage of this disease, the progressive atrophy of 
pigment epithelium and choriocapillaris lead to a large area of geographic atrophy. 
By then the retinal vessels may show mild to moderate constriction. Finally, it 
should be noted that expression and progression of the flavimaculatus flecks show 
great inter- and intrafamilial variability and that there is no evident correlation 
between progression of the fundus appearance and deterioration of vision (Merin 
and Landau, 1970; Deutman, 1971; Krill and Deutman, 1972b; Fishman, 1976; 
Notting and Pinckers, 1978; Noble and Carr, 1979; Deutman, 1989). 
In early cases the only sign of this disease in fluorescein angiography is 
sometimes an invisibility of the choroidal circulation, accompanied by a few 
parafoveal hypo- and hyperfluorescent spots. The invisibility of the choroidal 
circulation, originally called 'le signe du silence choroïdien', is often limited to the 
area between the hyperfluorescent spots and appears to be due to an accumulation 
of lipofuchsin within the pigment epithelial cells. As the disease progresses, new 
flecks that occur are usually non-fluorescent, but due to resorption of older flecks, 
the number of hyperfluorescent spots increases and these confluate progressively 
(Figure 3 and 4). In late stages, the secondary atrophy of the choriocapillaris leads 
to a central atrophic area in which the choroidal vessels can be seen (Figure 2 and 
5; Krill, 1966; Bonnin et al., 1976; Anmarkrud, 1978; Fish et al., 1981). 
In early stages, the photopic and scotopic ERG are usually normal or show a 
slight delay in reaching a normal maximal b-wave amplitude. In later stages, 
especially when the area of atrophy is very large, the ERG may be subnormal or 
abnormal (Carr, 1965; Deutman, 1971; Noble and Carr, 1979; Moloney et al., 
1983; Pinckers and Deutman, 1987). 
The EOG ratio varies from normal to subnormal. Subnormal readings are more 
often found in patients with diffuse flecks (Deutman, 1971; Noble and Carr, 1979; 
Moloney et al., 1983). 
Stargardt's disease involves a type I acquired red-green defect (Pinckers, 1971). 
In the very early stages a blue-yellow defect is noted. As soon as fixation becomes 
eccentric, an acquired type I red-green defect develops, characterized by diminished 
red-sensitivity and, later on, by scotopisation. Ultimately an acquired central 
achromatopsia may be encountered (Pinckers, 1971; Notting and Pinckers, 1978). 
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Figure 2. Right eye of thirty-nine-year old female patient with an atrophic stage of Stargardt' s disease. A 
hypofluorescent area (dark choroid) with several hyperfluorescenl spots surrounds the central lesion. 
Figure 3. Same patient as figure 2. Left eye. Classical picture of Stargardt's disease with small hyperfluorescenl 
spots in the posterior pole. 
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Figure 4. Right eye of thirty-eight-year old female patient with Slargardt's disease. Hypofluorescent spots 
surrounded by 'dark choroid'. In the centre the spots confluale. 
ЩЁ&Г 
Figure 5. Same patient as figure 4. Left eye. Due to additional atrophy of the choriocapillaris the choroidal 
vessels are visible. 
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The mid-peripheral areas reveal normal to slightly diminished sensitivity. A 
relative central scotoma is encountered at first, followed later by an absolute 
central scotoma (Deutman, 1989). 
Despite the fact that a lot of patients with Stargardt's disease have been 
described in detail in literature, only a few of these have been described in the 
atrophic end-stage of the disease. Several authors agree that it is difficult to 
differentiate this stage from the final lesion seen in CACD. In Stargardt's disease 
(unlike CACD), the first visual complaints often develop during the first decades of 
life, severe visual disturbances and a red-green colour vision defect precede the 
development of geographic atrophy by several years. Atrophic lesions are also 
often surrounded by whitish or yellow flecks and a surrounding dark choroid may 
be obvious in fluorescein angiography (Deutman, 1971; Fishman, 1976; Notting 
and Pinckers, 1978; Noble and Carr, 1979). 
1.2.3 Juvenile atrophy of the pigment epithelium and choriocapillaris 
In 1992 the case of two brothers, aged nine and ten years old, who were known 
to have an atrophic lesion in the posterior pole from the age of seven months, was 
reported (Hoyng et al., 1992). Both boys had a horizontal nystagmus and their 
visual acuity was 0.08 and 0.1 in both eyes. Ophthalmoscopy and fluorescein 
angiography showed a clearly demarcated area of atrophy of pigment epithelium, 
choriocapillaris and smaller choroidal vessels in the posterior pole. These lesions 
were surrounded by pigment clumps. The retinal vessels were moderately 
narrowed. The optic disks were small and flat and seemed to be hypoplastic 
(Figures 6 to 9). The electro-oculogram proved normal and the responses in 
electroretinography revealed only a slight abnormality. Colour vision tests 
confirmed a moderate acquired red-green defect in one boy and an anomaloscopic 
reduced red-sensitivity in the other. 
1.2.4 Central areolar pigment epithelial dystrophy 
In 1976 Fetkenhour et al. described a family with four affected individuals over 
three generations, in whom he found a parafoveal area of atrophy of the pigment 
epithelium. The age of the patients varied from thirteen to sixty years. Visual acuity 
was unaffected, except in one eye with a subretinal haemorrhage. ERG, EOG and 
dark adaptation were normal. Colour vision tests effected by means of HRR plates 
and the Famsworth 100-Hue test, revealed no abnormalities. Based on these 
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Figure 6. Right eye of a nine-year-old boy with juvenile atrophy of the pigment epithelium and choriocapillaris. 
Figure 7. Left eye of patient in figure 6. In both eyes the optic disk appears to be hypoplastic. 
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Figure 8. Right eye of ten-year-old boy, brother of patient in figures 6 and 7, with similar lesions. 
Figure 9. Left eye of patient in figure 8. 
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findings, Fetkenhour proposed the name 'central areolar pigment epithelial 
dystrophy' (CAPE dystrophy) for this disorder. Hermsen and Jurdisch (1984) 
reported the case of six female and one male family members, over three 
generations, suffering from CAPE dystrophy. Moderate vision loss was discovered 
in the one eye of one patient and in both eyes of another patient. One patient 
suffered a severe loss of visual acuity in both eyes. In the patients who had retained 
normal vision, the results of the ERG, EOG dark adaptation and colour vision tests 
(Farnsworth 100-Hue) were within normal limits. The tests were not performed on 
the patients who suffered a decrease in visual acuity. Kaesmann et al. (1992) 
discovered a CAPE dystrophy in six patients over three generations: four patients 
were younger than twenty-five years of age, one was fifty-three years old and 
another eighty-one years old. Fundoscopy revealed small parafoveal patches of 
atrophy of the pigment epithelium. Fluorescein angiograms were effected on the 
younger patients. Visual fields revealed a parafoveal scotoma in three of the 
patients. Retinal function tests were normal, however. 
The above-mentioned authors made the point that CAPE dystrophy had to be 
differentiated from other hereditary macular diseases because it was characterized 
by an autosomal-dominant, non-progressive atrophy of the parafoveal pigment 
epithelium with sound visual acuity and normal retinal function tests. However, 
there are several factors which make it difficult to differentiate CAPE dystrophy 
from CACD in these cases. In the three families reported, only two out of sixteen 
patients, older than fifty-five years of age, had good visual acuity. In the family 
reported by Hermsen, the older family members suffered moderate to severe vision 
loss. Retinal function tests were not performed on these patients. Several 
angiographic pictures demonstrated additional atrophy of the choriocapillaris. This 
was not described in some cases and could well fit into CACD stage III (chapter 
2.11). In several cases a parafoveal scotoma was encountered. It is possible that 
abnormalities may have been detected with more extensive colour vision testing. 
Recently (1992), Small et al. found that the patients of Fetkenhour and Hermsen 
and the large family with North Carolina macular dystrophy, share common 
ancestry. 
In conclusion, it is my contention that the reported cases of CAPE dystrophy 
bear a strong resemblance to CACD and North Carolina dystrophy. In my opinion, 
the families hitherto described, do not provide sufficient evidence to warrant the 
classification of CAPE dystrophy as a separate clinical entity. Well-documented 
reports on more families, with valid vision and retinal function tests up to 
senescence, could throw more light on the matter. 
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1.2.5 Progressive cone dystrophy 
Several disorders of the cone system, stationary as well as progressive, have 
been described (Goodman et al., 1963). This investigation will be confined to the 
study of progressive cone dystrophy, because the macular changes in this disorder 
may resemble CACD. 
Progressive cone dystrophy is a disorder which primarily affects the cone 
system. In advanced cases some patients develop a cone-rod dystrophy. Sporadic 
cases are more common than familial cases (François, 1974; Grey et al., 1977; 
Krill, 1977). The most common type of heredity is autosomal-dominant (Berson et 
al., 1968; Krill and Deutman, 1972a; Pearlman et al., 1974). Autosomal-recessive 
heredity has been reported on occasion (François, 1974; Krill, 1977; Gouras et al., 
1983). Families with X-linked heredity have also been described (Heckenlively and 
Weleber, 1986; Pinckers and Deutman, 1987; Verdoom and Pinckers, 1988; 
Jacobson et al., 1989; Keunen, 1990). By linkage analysis the gene in x-linked 
cone dystrophy was located at Xp21-pll.l (Meireet al., 1994). In most patients the 
disease is recognized during the first two decades of life. Loss of visual acuity and 
sometimes photophobia are the first complaints. Colour vision loss is occasionally 
an early symptom (Krill et al., 1973). In some patients a congenital nystagmus may 
be encountered (Krill, 1972; Krill et al., 1973). Varying ophthalmoscopic and 
angiographic changes may be found in the macula: a tapetal-retinal sheen 
(Heckenlively and Weleber, 1986), perifoveal hypopigmentation (François, 1974), 
a bull's eye pattern of hypopigmentation, a diffuse pattern of pigment clumping and 
a well-defined area of atrophy of pigment epithelium and choriocapillaris (Figure 
10; Krill, 1977) have all been described. The macula may even appear normal 
(François, 1974). Different fundus pictures may be encountered within one family 
(Krill, 1977). Associated ophthalmoscopic findings, like pallor of the optic disk, 
attenuation of the retinal arterioles and peripheral pigmentation have also been 
described (Krill et al., 1973). 
In most patients, the photopic ERG is abnormal, or even extinguished. However, 
the ERG is sometimes normal and in those cases, the diagnosis can only be 
confirmed by colour vision tests. Subnormal photopic ERG findings have also been 
reported in female carriers from a family with an X-linked trait (Amzallag et al., 
1990). The scotopic ERG is usually normal. In advanced cases, responses may be 
subnormal, especially when the rod system has become affected (Krill et al., 1973; 
François 1974). 
Gouras et al. (1983) found supernormal rod responses in a brother and a sister 
suffering from cone dystrophy. 
32 
REVIEW OF THE L I T E R A T U R E 
Figure 10. Righi eye of fifty-year-old patient suffering from cone dystrophy. Within the hyperfluorescent lesion an 
area of additional choriocapillaris atrophy is present. 
Dark adaptation may be normal or abnormal (Krill et al., 1973). The EOG is 
only subnormal in advanced cases. Although patients often do not complain about 
a deterioration of colour vision, colour vision test results often prove abnormal in 
the early stages of the disease. Based on the degree of eccentric fixation, and 
applying the depth-localization theory, Pinckers (1983) divided the early changes 
into a central cone disease and a peripheral cone disease. When only the central 
cones are affected, a red-green colour vision defect (Type I) will be detected. This 
applies in a majority of cases. When the disease begins with an atrophy of the 
peripheral cones, the blue cones are relatively more affected, resulting in a blue-
yellow colour vision defect (Type III). When the rod system is intact, scotopisation 
(i.e. anomaloscopic reduced red-sensitivity) will be found in both. Later in the 
disease, all cone types are affected and a deep central scotoma develops. The result 
is anarchic colour vision. Female carriers of a family with x-linked cone dystrophy 
may show a pseudoprotanomaly in colour vision tests and abnormal density 
differences in foveal densitometry (Keunen, 1990). 
Histopathological examination of the eyes of a seventy-eight-year-old woman 
suffering from cone dystrophy, showed an atrophy of the outer nuclear layers of 
cones and rods and atrophy of the temporal part of the disk. Dense deposits were 
found at the level of the retinal pigment epithelium (Vail and Shoch, 1965). 
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As already mentioned, in some cases of progressive cone dystrophy a well-
demarcated area of atrophy of pigment epithelium and choroid may be found in the 
posterior pole, resembling the later stages of CACD. This cannot be regarded as the 
end-stage of the dystrophy, because the same picture has been found in several 
young patients (Krill et al., 1973; François, 1974). 
1.2.6 Vitelliform dystrophy 
Vitelliform dystrophy can be divided into a form beginning at a youthful age, the 
so-called Best's vitelliform dystrophy, and a late-onset form, adult vitelliform 
dystrophy. These two forms show some similarities in the vitelliform stage of the 
disease. However, because there are also some morphological and electro-
physiological differences, they are regarded as two distinct entities. Both can give 
rise to an atrophic lesion in the posterior pole that may lead to confusion with CACD. 
Best's vitelliform dystrophy 
Best's vitelliform dystrophy is an autosomal-dominantly inherited disease that 
affects the retinal pigment epithelium of patients at a very young age. The 
alterations mostly present symmetrically, but the fundus findings are sometimes 
polymorph (Noble, 1977). The lesions are often detected during the first decades of 
life, but the classic 'egg-yolk' macular lesion may even be present in a neonate 
(Godei et al., 1986). Patients have been described by several authors (Cross and 
Bard, 1974; Miller et al., 1976; Maloney et al., 1977; Barricks, 1977; Noble et al., 
1978; Mohler and Fine, 1981; Godei et al., 1986) in various stages of this disease. 
In a large swedisch family the gene for this disease was located at 11 ql3 (Forsman 
et al., 1992) 
Deutman (1971) divided the evolution of vitelliform dystrophy into several stages: 
stage I: normal fovea, but EOG already pathological; 
stage II: the pre-vitelliform stage; small parafoveal lesions of the retinal pigment 
epithelium that appear as window defects in fluorescein angiography; a small 
yellowish dot or a tiny honeycomb structure in the fovea may appear; 
stage III: the vitelliform stage; macular alterations that resembles eggs 'sunny-side 
up'; this 'egg-yolk' macular lesion has sharply circumscribed borders and is 
usually slightly elevated; initially the lesion is dense, yellow opaque and appears 
essentially homogenous; fluorescein angiography shows hypofluorescence of the 
lesion, because the choroidal fluorescence is not transmitted; 
34 
REVIEW OF THE L I T E R A T U R E 
stage IV: the 'scrambled-egg' stage; in this stage the contents of the lesion becomes 
less homogenous and more fragmented; 
stage V: the pseudohypopyon stage; the yellowish material is now located between 
the retinal pigment epithelium and the sensory retina, giving rise to a fluid level; 
the fluid shifts when the head is tilted (Kraushar et al., 1982); 
stage VI: the round chorioretinal atrophy stage (Figure 11 ); this stage may develop 
after several years; subretinal neovascularisation may develop in about 10% of the 
eyes in this stage, eventually leaving a fibrous or vascularized scar (Mohler and 
Fine, 1981). 
Visual acuity often remains good until the pseudohypopyon stage, then a 
temporary loss of vision is noted. However, when the lesion reaches the atrophic 
stage, visual acuity will definitely drop to a level of about 0.3 (Mohler and Fine, 
1981). The EOG is altered in all patients, also in asymptomatic carriers (Deutman, 
1969; Cross and Bard, 1974). The ERG is normal. Colour vision tests reveal a red-
green defect (Deutman, 1971). 
Several authors described patients with multiple vitelliform cysts. In cases of 
small vitelliform lesions, as well as moderate-sized lesions, these can be multiple 
and large and possibly undergo rapid progression but yet be consistent with 
relatively acute vision (Deutman, 1971; Miller, 1977; Lisch et al., 1989). 
Figure 11. Righi eye of twenty-five-year-old male patient with atrophic vitelliform lesion. The right eye showed the 
'scrambled egg' stage. 
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Histopathological studies showed that Best's vitelliform dystrophy is a 
generalized disorder of the retinal pigment epithelium with accumulation of 
lipofuchsin granules within the retinal pigment epithelial cells and within 
macrophages in the subretinal space, particularly in the fovea. Later in the disease, 
severe loss of photoreceptors in the posterior pole also occurs (Weingeist et al., 
1982; Frangieh et al., 1982; O'Gorman et al., 1988). The atrophic stage of Best's 
vitelliform dystrophy resembles the end-stage of CACD. 
Adult vitelliform dystrophy 
Adult vitelliform dystrophy was first described by Gass (1974) as a peculiar 
foveo-macular dystrophy. Patients usually present in the fourth or fifth decade with 
complaints of mild loss of vision or slight metamorphopsia. Apart from the age of 
onset the disease differs from Best's vitelliform dystrophy in that the lesions are 
smaller and do not show the evolutionary changes of the foveal lesion. 
Furthermore, the EOG is normal or just slightly reduced. The foveal lesion is 
characterized by an oval-shaped or round subretinal lesion of about one-third to 
one-half disc in diameter. Fluorescein angiography shows a characteristic ring of 
Figure 12. Left eye of fifty-year-old male patient with adult vitelliform dystrophy. Central hypofluorescent lesion, 
surrounded by ring of hyperfluorescence. No other family members affected. 
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hyperfluorescence surrounding an area of hypofluorescence (Figure 12; Vine and 
Schatz, 1980). 
Subretinal neovascularisation rarely occurs (Vine and Schatz, 1980). A small, 
round atrophic lesion with loss of pigment epithelium and choriocapillaris has been 
described in the fellow eye of a patient with the typical picture of adult vitelliform 
dystrophy in one eye (Vine and Schatz, 1980), and in both eyes of the mother of an 
affected patient (Brecher and Bird, 1990). 
Fundus changes have been traced in several family members of affected 
patients, suggesting that this is an autosomal-dominant disorder. However, most of 
these family members were asymptomatic (Vine and Schatz, 1980; Brecher and 
Bird, 1990). 
1.2.7 Serpiginous choroiditis 
Serpiginous choroiditis is a rare, chronic, usually bilateral, inflammatory 
disorder of unknown cause. Most patients are middle-aged or older, but younger 
patients have been reported (Weiss et al., 1979). Initially only one eye may be 
affected. The process usually begins in the peripapillary region and extends in an 
irregular fashion to the mid periphery. It may occur in more than one area. 
Recurrent attacks have been noted over months and even over years. The acute 
lesion is at the level of the retinal pigment epithelium or inner choroid and has a 
greyish-white appearance. In general, lesions have a geographic appearance and the 
borders with normal tissue are clearly demarcated (Figure 13). The lesion is active 
for several weeks before it lightens and becomes pigmented. Apart from 
hyperpigmentation, older lesions show fibrous scar tissue and loss of pigment 
epithelium and choroid. Most patients present when vision is severely affected and 
the process extends to involve the macula (Baarsma and Deutman, 1976; Chisholm 
et al., 1976; Weiss et al., 1979). In some of the reported cases, the central scotoma 
becomes less deep and visual acuity recovers in varying degrees, several weeks 
after the attack (Weiss et al., 1979). However, visual recovery has been 
encountered only rarely (Laatikainen and Erkkila, 1981; Hamilton and Bird, 1974; 
Schatz et al., 1974). On fluorescein angiography, the acute lesion is 
hypofluorescent until the late stages. This hypofluorescence has contributed to the 
non-perfusion of the choriocapillaris (Hamilton and Bird, 1974; Schatz et al., 1974) 
and to a blockade by the retinal pigment epithelium (Mansour, 1988b). It resembles 
the non-perfusion of the choriocapillaris noted in acute multifocal placoid pigment 
epitheliopathy (Deutman and Lion, 1977). Sometimes staining of the vein wall 
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over the affected area indicates a focal area of retinal phlebitis (Gass, 1987). Old 
lesions show progressive hyperfluorescence, diffusing from the neighbouring 
choriocapillaris in the late stages of the angiogram. An anterior chamber 
inflammatory reaction can occasionally be seen and vitreous cells are found in one-
third of the patients (Masi et al., 1978). Unusual findings encountered sometimes, 
include focal retinal phlebitis, branch vein occlusion, optic disk neovascularisation 
and retinal neovascularisation (Gass, 1987). Choroidal neovascularisation has been 
observed by several authors. 
This neovascularisation has sometimes been treated successfully by argon laser 
(Chisholm et al., 1976; Jampol et al., 1979; Laatikainen and Erkkila, 1981; 
1982;Mansour, 1988b; Wu et al., 1989). In severe cases, when large areas of the 
fundus are affected, the ERG and EOG may be abnormal (Chisholm et al., 1976). 
It is not clear whether systemic corticosteroids are effective in the treatment of 
serpiginous choroiditis. Improvement of visual acuity has been reported in eyes in 
an acute stage, after treatment with Cyclosporin-A (Secchi et al., 1991). 
In macular serpiginous choroiditis the lesions begin in the macula. Unlike 
classical serpiginous choroiditis, these patients present early in the course of the 
disease. Because of the early involvement of the macula, the visual prognosis is 
Figure 13. Left eye of thirty-five-year-old male patient with serpiginous choroiditis. Demarcated area of atrophy 
of pigment epithelium and choriocapillaris. Four years later subretinal neovascularisation developed. 
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less favourable than in the peripapillary form. Ophthalmoscopic and angiographic 
findings correspond with those described in patients suffering from the classical 
disease. Choroidal neovascularisation has been reported in about one-third of the 
published cases (Hardy and Schatz, 1987; Mansour, 1988b). 
Some authors have reported cases of CACD that, in my opinion, may have been 
a misinterpretation of old serpiginous lesions (Franceschetti, 1963a, p.644; Krill, 
1977,p.949). 
1.2.8 Macular colobomata (Dysplasia) 
Macular colobomata are congenital, non-progressive lesions, characterized by 
atrophy of pigment epithelium, choriocapillaris and choroid in the macula. They 
can be either sporadic or hereditary (familial). The clinical picture may vary, 
because both can be associated with other ocular or systemic disorders (Phillips, 
1970). 
Mann (1957) proposes the term 'dysplasia' for this condition, because from an 
embryological point of view the term 'coloboma' would suppose a closure defect 
of the foetal ocular cleft. This seems unlikely when it concerns the macula. 
Sporadic cases 
Based on two categories described by Bock (1893), Mann (1957) divided 
sporadic macular colobomata into three categories according to their 
ophthalmoscopical appearance: 
a. A pigmented macular dysplasia with atrophy of pigment epithelium and 
choriocapillaris with small patches of bare sclera: 
The lesion is covered with dense, irregularly arranged pigment clumps. There is no 
ectasia of the base. The overlying vessels are not abnormal. 
b. A поп-pigmented dysplasia with an oval patch of bare sclera: 
The floor of the lesion is ectatic and the edge of the lesion shows individual 
patches of grouped pigmentation. 
с Macular dysplasia with abnormal vessels: 
These are very rare. They are colobomata of the non-pigmented type with 
anastomosis of the upper temporal branch of the arteria centralis retinae with a 
vessel protruding through the floor of the lesion or with vessels that arise from the 
coloboma and then course forward into the vitreous. 
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Mann suggested that an intra-uterine infection was the cause of this disorder in 
most cases and that it was not a developmental abnormality. 
The high incidence of macular colobomata accompanying developmental 
abnormalities suggests that this disorder is a failure of retinal development (Moore 
et al., 1985). In general the ERG is normal in patients who have a macular 
coloboma. 
Associated abnormalities which have been reported, are the following: 
1. With abnormal ERG findings. In a retrospective study of thirty-six patients with 
congenital and early-onset retinitis pigmentosa, Foxman et al. (1985) mentioned 
two patients with Leber's congenital amaurosis and bilateral macular colobomata. 
Heckenlively (1988a) described seven patients with bilateral macular 
colobomata and abnormal ERG findings. In four of these, the findings were similar 
to Leber's congenital amaurosis and in three to progressive cone-rod dystrophy. 
Because these cases resembled other cases described in two or more siblings, he 
believed them to have an autosomal-recessive pattern of heredity. Freedman and 
Gombos (1971) described a patient with bilateral keratoconus, macular colobomata 
and retinitis pigmentosa. Leighton and Harris (1973) reported a case of bilateral 
retinal aplasia in association with macular colobomata, keratoconus and cataract. A 
case of bilateral macular coloboma with progressive atrophy of the retina was 
mentioned by Fuñada et al. (1989). Moore et al. (1985) reported three cases of 
bilateral macular colobomata with progressive retinal dystrophy. In two of these 
cases, a hypoplasia of the optic disk was also present. One of these two was 
associated with polydactylism and the other with colpocephaly. 
2. With hypercalciuria. Idiopathic hypercalciuria, high congenital myopia and 
atypical macular coloboma were described by Gil-Gibemau et al. (1982) in a nine-
year-old boy and a thirteen-year-old girl. In the girl, only the left eye showed a 
macular coloboma. 
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Figure 14. Pedigree of family with hereditary macular colobomata (courtesy of Pasman and Pinckers). 
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3. Others. Car (1925) reported a case of bilateral macular colobomata and 
microcephaly. 
Familial cases 
Clausen reported the occurrence of macular colobomata in a father and son and 
four other members of the same family. Thereafter, several other families with an 
autosomal-dominant heredity pattern have been described (Figure 14 and 15; 
Clausen, 1921; Gesell and Blake, 1936; Jameson, 1937; Waardenburg, 1938 & 
1963; Tamaki et al , 1979; Pasman and Pinckers, 1982; Satorre et al., 1990). 
The occurrence of macular colobomata together with other systemic or ocular 
disorders has also been reported in two or more generations or two or more 
siblings: 
1. With abnormal ERG findings. Margolis (1977) described a combination of 
Leber's congenital amaurosis and bilateral macular colobomata in two siblings. 
The patients also suffered from deafmutism, severe myopia and enlarged corneas. 
Figure 15. Typical macular coloboma in patient I1I-4 from pedigree in figure (courtesy of Pasman and Pinckers). 
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Marayama (1989) described Leber's congenital amaurosis and bilateral macular 
colobomata in two siblings. Macular colobomata and retinal aplasia in a sibship of 
two males was reported by Phillips et al. (1981). Miller and Bresnick (1978) 
reported a mother and a daughter with bilateral macular colobomata with 
diminished and extinguished ERG responses. Heckenlively et al. (1979) mentioned 
a combination of retinitis pigmentosa, macular colobomata and nystagmus in two 
pedigrees. 
2. With idiopathic hypercalciuria. Meier et al. (1979) described two siblings from a 
consanguineous family suffering from nephrocalcinosis and nephrolithiasis caused 
by idiopathic hypercalciuria. The condition was associated with macular 
colobomata and tapeto-retinal degeneration. Gil-Gilbemau et al. (1982) described 
idiopathic hypercalciuria, high congenital myopia and atypical macular colobomata 
in a ten-year-old boy and his five-year-old sister. 
3. With skeletal abnormalities. Sorsby (1935) described a mother and her five 
children all of whom had bilateral pigmented macular colobomata in association 
with apical dystrophy of hands and feet. Phillips and Griffiths ( 1969) reported the 
case of a brother and a sister with bilateral macular colobomata, cleft palata, hallux 
valgus and flexion deformity of the distal interphalangeal joints of both little fingers. 
The girl also had delayed sexual maturity, retarded growth, recurrent dislocation of 
the left patella, bilateral coxa valga and genu valgum, and very short feet. 
1.2.9 Sorsby's fundus dystrophy 
This condition was originally described by Sorsby et al. (1949) in four 
pedigrees. It has been named 'Sorsby's pseudo-inflammatory macular dystrophy'. 
As Hamilton et al. (1989) have pointed out, this name can be confusing, however, 
because 'pseudo-inflammatory' is not a helpful adjective and 'macular' ignores the 
peripheral extension of the disease. 
The three key features of the dystrophy described by Sorsby are: autosomal 
heredity, loss of central vision before the sixth decade of life and blindness during 
the seventh decade. Three variations of this disease have been described. The 
largest group shows macular subretinal neovascularisation and yellow or white 
subretinal spots. The process of atrophy gradually involves the whole fundus. Poor 
night vision is a common symptom (Sorsby et al., 1949; Bum, 1950; Hoskin et al., 
1981; Capon et al., 1988; Hamilton et al., 1989). In the second group, no yellow 
fundus spots are seen and poor night vision is not noted (Sorsby et al., 1949; Fraser 
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and Wallace, 1971). In the last group there is progressive atrophy without 
subretinal neovascularisation (Sorsby et al., 1949; Polkinghome et al., 1989). 
Neither of the two latter groups reveal nyctalopia. 
In several cases a prolonged filling of the choriocapillaris has been noted 
(Hoskin et al., 1981; Capon et al., 1988; Polkinghome et al., 1989). This may be 
due to accumulation of debris in Bruch 's membrane. 
The results of colour vision tests, ERG and EOG depend highly on the extent of 
atrophy. In patients with severe atrophy these tests are often abnormal. However, in 
patients without complaints, but with small spots of atrophy of the retinal pigment 
epithelium in the macula, colour vision tests may already show a blue-yellow 
defect (Hamilton et al., 1989). 
A histopathological study of an eye from a patient belonging to the first group, 
showed lipid-containing amorphous deposits between the basement membrane of 
the retinal pigment epithelium and the inner collagenous layer of Bruch's 
membrane. Furthermore, there was large-scale loss of the outer retina, the retinal 
pigment epithelium was discontinuous, and there was atrophy of the 
choriocapillaris (Capon et al., 1989). 
Before the atrophy of pigment epithelium spreads to the far periphery of the 
fundus, the disease may resemble CACD. 
1.2.10 North Carolina macular dystrophy 
North Carolina macular dystrophy is a rare, autosomal-dominant disorder with 
complete penetration and variable expressivity. Lefler et al. (1971) first described 
this disorder in a family of five hundred and forty-five members spanning seven 
generations. In the original report the disease was called 'hereditary macular 
degeneration with amino-aciduria'. However, the amino-aciduria was later found to 
exist independently from the retinal disorder (Frank et al., 1974). In 1989 Small 
reported on the fundus changes in twenty-two affected patients of the originally 
reported kindred. The youngest affected individual was three months old. After a 
follow-up period of 10 years, he only found slight ophthalmoscopic changes in one 
patient (Small et al., 1991). He agreed with Gass (1987) that this is generally a 
stationary disorder, probably present at birth. Recently (1992a), Small et al. 
discovered that the family members with CAPE dystrophy described by 
Fetkenhour et al. (1976), have the same ancestors. The gene for this disease was 
located at 6ql3-q21 (Small et al., 1992b) So, these two disorders probably 
constitute the same disease. Affected family members can be classified according 
to three stages of development: 
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stage 1: tiny macular specks and pigment-epithelial irregularities; 
stage 2: variable halo of atrophic pigment epithelium, surrounded by confluent 
specks; 
stage 3: area of central choroidal atrophy, sometimes with staphylomatous or 
excavated appearance; fibrous tissue surrounds the edges. 
In all stages drusen-like changes can be found in the periphery (Small, 1989). 
Visual acuity ranges from 1.0 to 0.3 in the first two stages and from 0.5 to 0.1 in 
stage 3. 
It is probable, as Small also indicates, that the fundus picture described by Leveille 
et al. (1982) as 'autosomal-dominant central pigment epithelial and choroidal 
degeneration', is probably the same as North Carolina macular dystrophy. Stage 3 
may resemble the atrophic stage of CACD. 
1.2.11 Benign concentric annular macular dystrophy 
In 1974 Deutman described a family with an autosomal-dominantly inherited 
annular macular dystrophy that he termed 'benign concentric annular macular 
dystrophy' (BCAM dystrophy). In 1982 Coppeto and Ayazi reported a second 
family. Van den Biesen et al. (1985) published findings after following up the 
family Deutman had originally described, for ten years. 
In most patients vision was normal even in senescence. Fundoscopy and 
fluorescein angiography showed a ring of atrophy of the pigment epithelium 
encircling the fovea. The ERG and EOG were often normal. Colour vision tests 
showed a blue-yellow defect with pseudoprotanomaly (Deutman, 1974; Coppeto 
and Ayazi, 1982). However, some middle-aged patients noticed deteriorating 
vision. Their visual acuity was moderately affected. Besides atrophy of the retinal 
pigment epithelium, fluorescein angiography sometimes showed parafoveal 
patches of additional atrophy of the choriocapillaris in these patients. In some cases 
bone spicule-like lesions were found in the periphery of the retina and subnormal 
or abnormal rod and cone responses were reported in ERG tests (Van den Biesen et 
al., 1985). Deutman concluded that this dystrophy might be a pigmentary 
dystrophy with the functional characteristics of a cone-rod dystrophy (Deutman, 
1989). It would be interesting to gain access to the reports of the follow-up of 
Coppeto's family, in order to confirm this supposition. 
Stage III of CACD may resemble the fundus picture of BCAM dystrophy with 
choriocapillaris atrophy. 
All the dystrophies of the posterior pole described in chapter 1.2, may show 
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resemblance to central areolar choroidal dystrophy. Once the development of 
central areolar choroidal dystrophy has been described and discussed, it will be 
differentiated from above-mentioned diseases in chapter 4.3. 
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MATERIAL AND METHODS 
2.1 Patients 
When this investigation into the course of CACD was initiated in 1987, several 
family members of the Gu. and Ja. families, suffering from advanced-stage CACD, 
were known in our department. In order to obtain as many cases as possible from 
these large families, sixty-nine members of the families were visited in 1988 and 
1989. During visits, any visual complaints were noted and visual acuity was 
determined as accurately as possible. Direct and binocular indirect ophthalmoscopy 
was performed in maximal mydriasis after administration of 0.5% tropicamide and 
5% phenylephrine drops. Fundus photographs were made by means of a portable 
KOWA funduscamera. When fundus alterations were spotted or suspected in 
ophthalmoscopy or after evaluation of the fundus photographs, the patients were 
asked to visit our clinic for further examination. Because the first results were 
encouraging, family members of patients from five additional families with a 
possible autosomal-dominant trait of CACD, were also asked to attend our institute 
for ophthalmic examination. When fundus alterations were visible or suspected in 
examination with larger magnification, patients were asked to undergo fluorescein 
angiography. Because of the long duration of the (electro-) physiological tests and 
because abnormalities were not suspected in the very early stages of CACD, 
patients were only asked to undergo these examinations when abnormalities were 
detected in fluorescein angiography. Clinical and (electro-) physiological data 
concerning seven sporadic cases known in our institute, were also scrutinized. 
A summary of the results of the clinical examination of each affected patient is 
given in appendix I. The pedigrees of the seven families are given in appendix II. 
The ophthalmological examinations described or mentioned in this thesis, were 
performed by the methods and with the aid of the equipment mentioned below. 
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2.2 Visual acuity 
Visual acuity was measured on a Snellen chart at a distance of 6 meters. When 
the largest optotypes could not be read, the ability to count fingers (cf.) at different 
distances was determined. 
2.3 Slitlamp examination 
Slitlamp examination was performed by means of a Haag-Streit or Rodenstock 
(several types) slitlamp, before and after mydriasis was achieved by giving 
tropicamide 0.5% and phenylephrine 5% drops. 
2.4 Ophthalmoscopy 
Direct, indirect binocular ophthalmoscopy and contact lens examination by 
means of a three-mirror Haag-Streit lens, were used in assessing the posterior pole. 
A 60 dioptre lens in combination with a slitlamp was used when fluorescein 
angiography, immediately after ophthalmic examination, made the use of 
methylcellulose undesirable. 
2.5 Fundus photography and fluorescein angiography (FAG) 
A Topcon or Nikon 50 degree fundus camera was used for photographic and 
fluorescein-angiographic examination. Kodak Ektachrome, Trix and T-max 
photographic films were used. For fluorescein angiography, 5 ml of a 20% solution 
of sodium fluorescein was rapidly injected into a vein of the forearm. Immediately 
after injection photographic images were taken about every second until the 
arterio-venous filling phase was reached. Then images were devised with 
increasing intervals of time until about 10 minutes after injection. After 
developing, the images were printed as positives on a Kodalith transparent contact 
sheet. All photographs and fluorescein angiograms of patients who were not 
examined personally by the author, were re-evaluated individually. 
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2.6 Indocyanine green video-angiography 
For this purpose a digital videocamera, attached to a modified Topcon camera, 
was used. After injection of 50 mg indocyanine green (in 2,5 cc solution) into a 
peripheral arm vein, images were displayed on a high-resolution monitor and 
frames were recorded on an optical disk (eye resolution 1024 system). 
2.7 Electroretinography (ERG) and dark adaptation (DA) 
The patient was asked to lie on an examination bed. Mydriasis was achieved 
with tropicamide 0.5% and phenylephrine 5% drops. Oxybuprocaine 0.4% drops 
were applied as a local anaesthetic and a scleral contact lens equipped with 
measuring electrodes was inserted. A reference electrode was applied to the middle 
of the forehead, while the patient was earthed by means of two ear-clip electrodes. 
The patient faced a modified sphere of a Goldmann-Weekers adaptometer, lit by 
two 40W incandescent lamps in order to furnish a Ganzfeld adaptation. A xenon 
flash was used for stimulation by flashes. Measurements were recorded at photopic 
and scotopic (after a 12-min. dark adaptation) adaptation levels. Recorded electric 
potentials were plotted in a diagram against flash intensity (Thijssen et al., 1974). 
In the cases described in the following chapters, the saturation level of the b-wave 
was noted under photopic circumstances. 
2.8 Electro-oculography (EOG) 
The patient faced the same sphere that was used for ERG measurements. Skin 
electrodes were placed near the canthi interni and extemi of the eyes. After pre-
adaptation at 100 lx for about 15 minutes, the sphere was made dark for twelve 
minutes and the EOG was recorded at intervals of two minutes during this period. 
Then the sphere was adjusted to 2.500 lx and measurements were continued every 
minute for a further fifteen minutes. The dark trough (DT) was determined as the 
mean of the values between the sixth and twelfth minute and the light peak (LP) 
was determined from the mean of the four maximum values during the light 
adaptation period. The ratio lp/Dt ratio was calculated. (Thijssen et al., 1974) 
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2.9 Colour vision 
Except for the anomaloscope examination, colour vision testing was under 
standardized conditions: six Philips fluorescent tubes colour57, colour rendering 
index 96, providing 1.750 lux at the level of the test table. A test battery was used 
(Pinckers, 1984a). For screening purposes the Tokyo Medical College test (TMC) 
and the Farnsworth Panel D-15 test (D-15) or box 4 of the New ColourTest (NCT 
6/4) were used. A shortened Lightness Discrimination Test (LDT) was part of the 
NCT testing procedure (Pinckers 1984b). When the TMC testing result proved 
normal, the Ishihara test (edition 1970) was performed. When a patient failed the 
TMC test, the American Optical Hardy Rand and Rittler test (HRR) was used. After 
introduction of Standard Pseudoisochromatic Plates part 2 (SPP2), a test designed 
for the detection of acquired colour vision defectiveness, this test was included in 
the test battery (Pinckers et al., 1985). When the D-15 test result was normal, the 
desaturated Panel D-15 test (D-8/2) was used; when the D-15 test result was 
abnormal, box 8 of the NCT (NCT 8/4) was used. If possible, the patient was asked 
to undergo the Farnsworth-Munsell 100 Hue test (100 Hue) and an anomaloscope 
examination (Nagel Model II or Neitz ОТ). When colour vision examination proved 
to be impossible, the patient was asked to denominate great coloured surfaces red, 
green, yellow and blue at the patient-preferred distance (Pinckers, 1984a). In the 
interpretation of test results, age effects were taken into account (Pinckers, 1980). 
2.10 Visual fields 
As a kinetic method, the photometrically standardized Goldmann perimeter (V-
4 test object: 1000 asb; eyeball illumination 31,5 asb) was applied. Static 
measurements were performed by means of a Rodenstock Peritesi (single and 
multiple stimuli with 17 luminance steps of 0.2 logU; background luminance 1 
cd/m2) and in a few cases, the Oculus Friedman field analyzer. Some patients were 
tested by means of an Umazume-Ohta test (Pinckers, 1976). 
2.11 Staging of central areolar choroidal dystrophy 
The development of a retinal dystrophy is mostly a continuum of fundus 
alterations. However, to describe these changes and to compare the different 
findings in our patients, it has proved useful to divide the development of CACD 
into several stages. 
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Krill (1977) described four stages, based on fluorescein angiographic and 
routine ophthalmoscopic findings in patients in whom areas of atrophy of pigment 
epithelium and choriocapillaris were already present. He derived his findings on 
the early stages of CACD from ophthalmoscopic and angiographic changes he 
noted just outside the borders of large atrophic lesions. 
Based on different ophthalmoscopic and angiographic pictures, described by 
Krill and other authors (Carr, 1965; Deutman, 1971; Noble, 1977), four stages of 
CACD were distinguished during our investigation: 
stage I: doubtful or slight parafoveal pigmentary changes seen with contact lens or 
60 dioptre lens; fluorescein angiography shows a mottled hyperfluorescence that 
does not encircle the whole fovea; 
stage II: ophthalmoscopically evident alterations of the parafoveal pigment epithe­
lium; hyperfluorescent spots, sometimes intermingled with hypofluorescent areas 
encircle the intact fovea more than 180 degrees in angiography; 
stage III: same findings as in stage II, but also one or more areas of atrophy of 
choriocapillaris enhancing the visibility of the choroidal vessels throughout all 
phases of fluorescein angiography; the fovea seems not affected; 
stage Г : same findings as in stage III, but now the fovea is also affected by 
atrophy of the choriocapillaris. 
The first two stages could also be referred to as 'probable CACD', because up 
to the present, no study has been published describing the development of CACD 
through all stages in one individual. 
50 
CHAPTER 3 
RESULTS 
3.1 Geographical distribution 
Although patients from several provinces in the south-eastern part of the 
Netherlands are referred to the academic hospital of Nijmegen, it is striking that, at 
the time of examination, most (twenty-four of the thirty described) of affected 
family members lived in the province of Limburg. It is also noticeable that in the 
case of six of the seven families concerned, the eldest traceable family members 
originated from this province. I could not find evidence that any of the families 
were related to each other. Patients with a sporadic form of CACD seem to be less 
clearly localized. Places of residence of affected family members as well as 
sporadic cases at the time of their first examination, are given in figure 16. 
3.2 Number of patients 
From the seven families concerned, thirty patients with various stages of CACD 
were identified. As already mentioned in chapter 1.2.1 the first two stages of 
CACD could also be referred to as 'probable CACD'. In our patients who suffered 
from stage one or two of the disorder, no history or manifestations of systemic 
diseases, prolonged treatment with medical drugs or other ocular diseases could 
explain the macular alterations adequately. The majority of patients revealed the 
same stage of CACD in both eyes. Different stages were found in six persons (Gu. 
III-7, III-9, III-12, Te. IV-10; Li. III-3, III-4). In one patient (Ho. III-l), the stage of 
CACD could not be determined with accuracy, because the findings in the initial 
examination could not be checked on fundus photographs or fluorescein 
angiograms. However, a detailed description by the examiner and the outcome of 
various tests made a stage II CACD most likely. 
51 
C H A P T E R 3 
+ V 
Maastricht 
о 
Δ 
Π 
# 
+ 
V 
О 
© 
= fam. Gu. 
= fam. Ja. 
= fam. Si. 
= fam. Sta. 
= fam. Te. 
= fam. Ho. 
= fam. Li. 
= sporadic cases 
Figure 16. Geographica! distribution of the affected family members and sporadic cases. 
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The number of eyes with CACD and the relevant stages are listed in table 1. 
Family Stage 
Gu. 
Ja. 
Si. 
Sta. 
Te. 
Ho. 
Li 
sporadic 
I 
— 
4 
2 
2 
-
-
-
— 
II 
4 
-
-
-
3 
4 
1 
1 
III 
5 
2 
2 
-
3 
2 
4 
11 
IV 
7 
8 
-
4 
2 
-
1 
2 
(No. 
Total 
, of patients) 
16(8) 
14(7) 
4(2) 
6(3) 
8(4) 
6(3) 
6(3) 
14(7) 
Total 8 13 29 24 74(37) 
Table I Distribution of different stages of CACD within the families and amongst sporadic cases. 
3.3 Age and gender distribution 
Gender distribution of affected persons is indicated in table 2. 
Male Female Total 
Family study 15 15 30 
Sporadic cases 3 4 7 
Table 2. Gender distribution m CACD patients. 
Gender distribution in the families have a 1:1 ratio. This corresponds with the 
postulated autosomal-dominant transmission mode described in chapter 1.1.11. 
Amongst the sporadic cases there also seems to be no sex predilection. 
The age distribution of the patients from the family studies and sporadic cases are 
listed in table 3. The number of patients indicated exceeds the total of 37 examined 
patients, because patients with two different stages of CACD are listed twice. 
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Age Stage I II III IV 
20-30 
30-40 
40-50 
50-60 
60-70 
3 
1 
-
-
— 
3 
1 
3 
-
1 
1 
2 
6 
7 
2 
_ 
-
3 
5 
6 
Table 3 Age distribution according to the various stages ofCACD. 
As was to be expected, patients suffering from the earlier stages of CACD were 
younger than the patients in more advanced stages. Amongst the sporadic cases, the 
ages varied from thirty-nine to sixty years. 
3.4 Age of onset of visual complaints 
In the family studies, seven male patients mentioned their first visual 
disturbances as occurring between the ages of thirty-seven and fifty-five (with a 
mean age of forty-six years). In the ten female patients who mentioned the age of 
onset, the range was from twenty-five to fifty-two years (with a mean age of 45.2 
years). Eight patients had no visual complaints and in another eight patients the age 
of onset was unknown. Amongst sporadic cases, the age of onset varied from 
twenty-nine to forty-nine years (with a mean age of forty-two years). 
Although the relatively small group of patients make statistic deductions 
difficult, there seemed to be no difference in the age of onset between male and 
female cases, nor between familial and sporadic cases. 
3.5 Visual acuity 
Visual acuity of the eyes of patients in the family studies and of sporadic cases 
with respect to the various stages of CACD are listed in table 4. 
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Visual acuity Stage I II III IV 
1.0 8 10 4 -
0.6-0.8 - 3 16 
0.3-0.5 6 
0.1-0.25 - - 3 6 
f.c3-5m 4 
f.c0.5-2m - - - 14 
Table 4. Visual acuity (eyes) in various stages ofCACD. 
Table 4 shows that eyes with a CACD stage IV had severely reduced visual 
acuity, compared to eyes in the other stages. This emanates from the fact that stage 
IV has been defined as the stage in which the fovea shows atrophy of the pigment 
epithelium and choriocapillaris resulting in markedly lower visual acuity than the 
other stages in which the fovea has not yet been affected by this kind of atrophy. 
Therefore it is not surprising that several patients showing stage III in one eye and 
stage IV in the other, have fair eyesight in the former and poor eyesight in the latter 
eye. The table also shows that almost all eyes in stages I or II have sound visual 
acuity. Only one of the patients suffering from stage II ODS (Te. III-5) had visual 
complaints. Therefore patients with these stages of CACD can only be detected by 
examining family members of patients known to suffer from CACD. 
Almost all patients in stage III CACD had visual complaints. Patients with this 
stage were detected at their initial visit to an ophthalmologist. 
Most patients suffering from stage IV CACD were known to have had a long 
history of visual disturbance. 
3.6 Refraction 
The refraction of twenty-three patients from the families concerned and of all 
sporadic cases was determined subjectively. The spherical equivalent of these sixty 
eyes was calculated (spherical value - 1/2, cylindrical value in dioptres). The 
distribution of the spherical equivalents (rounded up in whole dioptres) of these 
sixty eyes, is presented in figure 17. 
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of eyes 
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Figure 17. Spherical equivalents of forty-eight eyes from the family studies and of 14 eyes of sporadic cases. 
Myopia was found more frequently than hypermetropia among patients from 
affected families. Of the 9 eyes with myopi of more than 4 dioptres, three patients 
(six eyes) belonged to the Te. family. 
Anisometropia of more than one dioptre was only found in 3 patients. 
Astigmatism of more than 2 dioptres was encountered in only two eyes. 
There seems to be no predilection for myopia, hypermetropia or severe 
astigmatism in CACD patients. 
3.7 Anterior segment 
In patients who were examined with slitlamp biomicroscopy no abnormalities 
were found. 
3.8 Ophthalmoscopy 
In order to render as clear a picture as possible of the fundoscopic changes in 
CACD, these will be discussed in terms of the stages described in chapter 2.1: 
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Stage I. In the family studies, eight eyes (belonging to four patients) with a stage I 
CACD were encountered. Fundoscopic changes were marked by slight 
hypopigmentation in the parafoveolar area. A normal foveal reflex was observed. 
In all patients, slight pigmentary changes were not obvious in indirect 
ophthalmoscopy. In three patients (Ja. III-3, Si. Ill-1 OS, Sta. II-1), this 
hypopigmentation could only be noted by means of a three-mirror contact lens, a 
60 dioptre lens or direct ophthalmoscopy. In two patients (Ja. III-9, Si. Ill-1 OD) 
these changes were still unclear or remained unobserved using these examination 
methods, but fluorescein angiography proved the presence of pigmentary 
alterations. 
Stage II. This stage was observed in twelve eyes (seven patients) in the family 
studies and in one eye among the sporadic cases (Table 1). Hypopigmentation 
surrounding the fovea was already obvious in indirect ophthalmoscopy. The 
diameter of the area of hypopigmentation varied from rather more than one disc 
diameter (Gu. IV-45, Te. III-5, Te. IV-10) in younger patients, to more than two 
disc diameters in middle-aged patients (Gu. 11-17, Ho. Ill-1 » III-2, Li. III-4). 
Hyperpigmentation, sometimes in a radial configuration, as could be seen in 
fluorescein angiography (see later), were not obvious with either of the methods of 
fundoscopy. The foveal reflex, retinal vessels and other parts of the retina were 
normal. Fundoscopic findings in the right eye of patient Wijn. (among the sporadic 
cases), resembled those described in the family cases. 
Stage III. This stage of CACD was observed in eighteen eyes of twelve members 
of the various families and in eleven eyes of six sporadic cases (Table 1). Although 
this stage is characterized by one or more areas of atrophy of the choriocapillaris, 
the phenomenon was not always obvious when using the various techniques of 
fundoscopy (Gu. Ill-1, Si. II-3, Ho. II-2, Kell.). When the atrophy of the 
choriocapillaris and pigment epithelium was visible in fundoscopy (Gu. III-7, III-9, 
Ja. II-1, Te. IV, Li-II-2, III-3, Ш-4, Clae., Vors, Trao, Wijn., Knip.), these lesions 
showed a rather golden-yellowish aspect with increased visibility of the underlying 
choroidal vessels. The colour originated from the reflexes of the choroid that were 
even more marked in large areas of atrophy of the pigment epithelium and 
choriocapillaris. In cases where this atrophy was not seen in fundoscopy, the 
atrophy of the pigment epithelium seemed more pronounced than in eyes with 
stage I or II. However, this could only be discerned after comparing the fundus 
photographs of the different eyes in different stages of CACD. 
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Stage Г . Twenty-two eyes of twelve patients from the affected families and two 
eyes of one patient among the sporadic cases, showed this stage of CACD (Table 
1). In all cases the atrophy of pigment epithelium and choriocapillaris was 
observed in fundoscopy. The extent of the lesion varied from a patch of atrophy of 
choriocapillaris within the areas of atrophy of the pigment epithelium (Sta. II-2, 
Jan.) to a large, often nearly round lesion of atrophy of both layers, the so-called 
end-stage of CACD (Gu. III-3, III-7, III-9, III-13, III-12, Ja. II-4, II-5, II-7, II-8, Te. 
ΠΙ-4, Li. ΙΠ-3). Within these lesions the choroidal vessels were clearly visible and 
had a rather reddish aspect, due to the absence of pigment epithelium. The lesion, 
as already mentioned above, had a rather golden-yellowish colour compared to the 
surrounding intact retina. Abnormalities of retinal vessels or other parts of the 
retina that could not be explained by physiological ageing were not noticed. 
3.9 Fluorescein angiography 
Fluorescein angiograms were effected with special attention to the first three 
stages of CACD. Family members who did not frequent our institute, but suffered 
from low visual acuity and were known to suffer from CACD - who were 
diagnosed in ophthalmoscopy during home visits as suffering from end-stage 
CACD - were not asked to visit our clinic for fluorescein angiography, because the 
picture of this stage is well known from literature and other patients described in 
this study. Fluorescein angiography was also not performed on young children 
without fundoscopic abnormalities. Several patients also refused fluorescein 
angiography. In ten family members (Gu. IV-23, Ja. III-2, Sta. ΠΙ-4, IV-I, IV-2, Ho. 
III-3, III-4, Li. IV-2, IV-3, IV-4), no abnormalities were found in fluorescein 
angiography. The angiographic picture found in the family studies and among the 
sporadic cases, will be described according to the stages mentioned in chapter 2.1. 
Stage I. Very delicate spots of hyperfluorescence were seen in the parafoveal 
region on the angiogram of the III-3 and III-9 siblings of the Ja. family (Figure 18 
and 19). These spots did not totally surround the fovea and were already obvious in 
the early phases of angiography. They did not enlarge or show signs of leakage of 
dye during subsequent phases. Therefore they can be regarded as so-called 
'window defects' of the retinal pigment epithelium. The same kind of alterations 
were seen in the right eye of patient Si. Ill-1 (Figure 20 and 21). In the left eye of 
this patient and in both eyes of patient Sta. III-3, the hyperfluorescent spots were 
more striking and confluated partly, most markedly in the lower quadrants of the 
parafoveal region. In these areas, small spots of hypofluorescence were 
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interspersed among the hyperfluorescent lesions. They were particularly evident in 
the arterial phase. No other angiographic abnormalities were found in these 
patients. 
Stage II. In this stage the fovea is totally surrounded by a mottled 
hyperfluorescence measuring two or more disc diameters. Only in patient Te. III-5, 
in whom the hyperfluorescence was due to high myopia - and less obvious in the 
arterio-venous and venous phase - the affected area seemed smaller, but careful 
examination of the arterial phase of her angiogram showed a more widespread 
hyperfluorescence. The mottled hyperfluorescence was intermingled with several 
spots of hypofluorescence. In young patients (Gu. IV-45, Te. IV-10 OS, Ho. III-l), 
these spots were located around the mid-periphery of the hyperfluorescent area 
(Figure 22 and 24), while in older patients ( Te. III-5, Ho. III-2, Li. III-4 OD), these 
spots were located in the periphery of the lesion, tending to a radial configuration 
(Figure 25). In patient Gu. Ill-17 (mother of Gu. IV-45!) a striking radial 
configuration could be seen (Figure 23). The fluographic alterations of patient 
Wijn., one of the sporadic cases, resembled those seen in patient Gu. IV-45 and Ho. 
III-2 of the family studies. No leakage of dye or other abnormalities were noted. 
Stage III. This stage was marked by additional choriocapillaris atrophy. This could 
clearly be observed by the increased visibility of the choroidal vessels underneath 
these lesions, especially in the early filling phase of the angiogram. In several 
patients ( Ja. II-1, Te. IV-10 OD, Ho. II-2, Li. ΙΠ-2, ΙΠ-4 OS, Vors., Wijn. OS) 
nearly round patches, in which the choroidal vessels were clearly visible, were 
located under and next to the fovea (Figure 26 to 28). Their sizes varied from less 
than one to about two disc diameters. The adjacent section of the lesion showed a 
picture as described in stage II. In cases Gu. III-9 (OD) and Clae. several partially 
confluating patches with ragged borders were noted. Large, bean-shaped lesions, 
partially enclosing the fovea, were noted in the angiogram of patient Gu. III-l, Li. 
III-3 (OD), Trao., Kell, and Knip. (Figure 29) In all aforementioned cases, the 
choroidal vessels within these lesions were most obvious in the early filling and 
arterial phases of the angiogram. After these phases, fluorescein started leaking 
from the borders to the inside, gradually blocking one's view of the choroidal 
vessels. In the late venous phase the lesions appeared as homogenous, 
hyperfluorescent patches. There seemed to be no delay in the transmission of dye 
through the choroidal vessels. In one patient (Si. II-1), several choroidal vessels 
could clearly be noted in the early phase, but they did not form well-demarcated 
patches, unlike the other cases. There were no marked differences between the 
angiograms of the sporadic cases and the family members. 
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Stage IV. In this stage the fovea is affected by the atrophy of pigment epithelium 
and choriocapillaris. In all eyes with stage IV CACD, a large central area was seen 
in which the choroidal vessels were clearly visible. The fluographic characteristics 
were identical to those described in stage III. In some patients (Gu. Ill-13, Sta. II-1, 
II-5, Li. III-3 OS), the lesions had a smooth, nearly round appearance (Figure 30), 
while in others (Gu. III-9, Jan.), the borders were more ragged (Figure 31). In two 
cases (Sta. II-1, Jan.), the number of small choroidal vessels, the so-called pre-
capillary arterioles (Krill, 1977), was reduced. 
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I 
Figure 18. Right eye of patient Ja. Il 1-3. Visual acuity 1.0 in both eyes. Slight hyperfluorescent spots in the 
parafovealar area. CACD stage I. 
ρ 
Figure 19. Same patient as figure 18. Left eye. The hypofluorescent spots are clearly visible in the arterial phase. 
CACD stage 1. 
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Figure 20. Righi eye of patient Si. 1111. Visual acuity 1.0 in both eyes. Small hypofluorescent spots are visible 
nasally to the fovea. CACD stage I. 
Figure 21. Same patient as figure 20. Left eye. The hyper- fluorescent spots are clearly visible under the fovea. 
CACD stage 1. 
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Figure 22. Left eye of patient Gu. IV-45. Visual acuity 1.0. Hypo- and hyperfluorescent spots surround the fovea. 
CACD stage II. 
Figure 23. Left eye of patient Gu. 111-17. Mother of patient in figure 22. Visual acuity 1.0. Mottled hypo- and 
hyperfluorescence. Hypofluorescent spots at the border of the lesion show a radial configuration. CACD stage II. 
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Figure 24. Left eye of patient Te. IV-IO. Visual acuity 1.0. Mottled hypo- and hyperfluorescence around the fovea. 
CACD stage II. 
Figure 25. Right eye of patient Ho. 111-2. Visual acuity 0.8. Mottled hypo- and hyperfluorescence surrounds the 
unaffected fovea. CACD stage II. 
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Figure 26. Righi eye of patient Li. III-2. Visual acuity 0.25 in both eyes. Atrophy of the choriocapillaris within the 
hyperfluorescent lesion. The choroidal vessels are visible. CACD stage III. 
Figure 27. Left eye of the patient in figure 26. Leakage of dye from the borders of the lesion in the late phase of the 
angiogram. CACD stage III. 
65 
CHAPTER 3 
Figure 28. Left eye of patient Vors. Visual acuity 1.0. Atrophy of pigment epithelium and choriocapillaris on either 
side of the fovea. CACD stage III. 
Figure 29. Left eye of patient Trao. Visual acuity 0.8. Lesion surrounding the fovea. Leakage of dye from the 
borders. CACD stage 111. 
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Figure 30. Left eye of patient Gu. II1-I3. Visual acuity c.fO.5 m. Demarcated area of atrophy of pigment 
epithelium and choriocapillaris. There seems to be atrophy of some of the smaller choroidal vessels. 
CACD stage IV. 
Figure 31. Right eye of patient Jan. Visual acuity 0.08. Large area of atrophy of pigment epithelium and 
choriocapillaris. Atrophy of the smaller choroidal vessels. CACD stage Г . 
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Figure 32. Indocyanine green video-angiogram in patient Si Ill-l. Small spots of atrophy of the pigment 
epithelium are visible in the red-free frame (top left). These spots correspond to the light spots noted in the late 
frame of the video-angiogram (bottom right). This may be due to atrophy of the choriocapillaris. 
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3.10 Indocyanine green video-angiography 
In 1993, while the clinical picture was unchanged, indocyanine green video-
angiography was performed in patient Si III-1 (Bottoni, 1993). 
Indocyanine green angiography showed that the fovea was surrounded by a ring 
of hypofluorescense (Figure 32, bottom left) in the area beneath the 
hyperfluorescent spots (probably atrophy of the retinal pigment epithelium) that 
were noted in fluorescein angiography (Figure 21). This might well be due to 
atrophy of the choriocapillaris. The choroidal vessels appeared normal. In the later 
phase of the indocyanine green video-angiogram, several small hyperfluorescent 
spots were noted that corresponded with atrophy of the retinal pigment epithelium 
(Figure 32, bottom right). 
3.11 Electroretinography and dark adaptation 
Recorded electric potentials were classified as abnormal when the b-wave did 
not exceed 100 pV in the photopic ERG and 150 pV in the scotopic ERG (after 12 
minutes of dark adaptation). The results are listed in table 5. Family and sporadic 
cases are listed together. 
Photopic Stage I II III IV 
Normal 4 5 12 5 
Subnormal - 8 9 5 
Scotopic (DA) 
Normal 4 10 16 8 
Subnormal - 3 5 2 
Table 5. Results of the ERG in forty-eight eyes of twenty-four patients. 
3.12 Electro-oculography 
The EOG is classified as subnormal when the Arden ratio (Lp/Dt) is lower than 
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1.80 (Pinckers and Broekhuyse, 1983). EOG values were obtained for nineteen 
patients (thirty-eight eyes), surveyed in family studies, and seven patients (fourteen 
eyes) suffering from sporadic CACD. Results with regard to the different stages of 
CACD are listed in table 6. 
Stage I II III IV 
Normal 4 9 17 7 
Subnormal 4 7 4 
Table 6. EOG in fifty-two eyes (family studies as well as sporadic cases) 
In eyes with subnormal values in stage II, the lowest value encountered was 1.70 
(Sta. III-5 OD, Ho. III-l OS). The lowest value in stage III was 1.51 (Gu. III-9). In 
stage IV, 1.43 (Jan.) was the lowest Lp/Dt ratio encountered. 
3.13 Colour vision 
The results of colour vision testing are arranged in an order, ranging from 
defects found in macular damage with foveal fixation (diminished red sensitivity, 
including pseudoprotanomaly; blue-yellow defect, including diminished red 
sensitivity) to defects found in macular lesions with eccentric fixation (red-green 
defect or combined red-green and blue-yellow defect, including in both cases 
diminished red sensitivity). Table 7 shows the results of the colour vision tests. 
Family and sporadic cases are listed together. 
Stage I II III IV 
Normal 2 6 1 -
Dim. red sens.(incl. pseudoprot.) 2 3 - -
B-Y defect (incl. dim. red sens.) - 3 5 -
R-G defect (incl. dim. red sens.) - - 2 -
R-G + B-Y defect ( incl. dim. red sens.) 1 15 8 
Table 7. Results of colour vision tests in forty-eight eyes of twenty-four patients. 
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3.14 Visual fields 
The results of kinetic and static methods are arranged in table 8 in an order, 
ranging from reduced paracentral or central sensitivity to absolute paracentral 
and/or central scotomas. In patient Sta. Ill-1, with a stage I CACD ODS, the UO 
test was normal, while the peritest revealed a paracentral reduced sensitivity in 
both eyes (Figure 33 and 34). In patient Ho. III-2, with a stage II CACD ODS the 
Friedmann perimeter showed a paracentral reduced sensitivity, while visual field 
tests with the Goldmann perimeter were normal. In both cases, abnormal results are 
included in table 8. The results of family and sporadic cases are listed together. 
Stage I II III IV 
Normal 
Paracentral reduced sens. 
Central reduced sens. 
Pericentral scotoma 
Central scotoma 
Pericentral and central scotoma 
2 
2 
-
-
-
_ 
2 
4 
2 
-
-
1 
3 
3 
4 
5 
1 
4 
Table 8. Results of visual field tesis in thirty-four eyes of seventeen patients. 
In the 2 and 3 'normal' results in stages II and III, the UO test was the only test 
used. 
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Figure 33. Static perimetry of left eye of patient Sta ¡III. CACD stage I. Reduced parafoveal sensitivity. 
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Figure 34. Static perimetry of left eye of patient Li. 111-4. CACD stage III. General reduced sensitivity, relative 
central scotoma with paracentral maximum. 
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3.15 CACD and other diseases: 
Central areolar choroidal dystrophy and perceptive hearing loss 
One of the patients examined, suffering from the sporadic type of CACD, 
complained of a simultaneous progressive loss of hearing. The patient's fundus 
picture and changing audiograms showed striking similarities to those of one of 
Deutman's patients. Because of this remarkable coincidence, it was decided to 
describe these cases in this chapter. 
Case Histories 
Case I. Patient Laz., male, date of birth: 18.12.28 
History: In 1979 the patient was referred to our clinic because of macular 
degeneration. The patient had experienced a gradual loss of vision over the 
previous four years. During the same period, he started to complain about tinnitus 
in both ears. Corrected visual acuity was 0.8 OD and 0.6 OS at the time. 
Ophthalmoscopy revealed a peripapillary atrophy of the retinal pigment epithelium 
and choriocapillaris ODS, hypopigmentation in the posterior pole OD and a large, 
demarcated area of atrophy of pigment epithelium and choriocapillaris in the 
posterior pole OS. The patient was examined by the author in 1990. He had 
become hard of hearing and felt that his vision had worsened slightly. 
Visual acuity: OD 0.8 corr. S +1.25 C-1.25 axis 175 
OS 0.4 corr. S +0.75 C-1.00 axis 25 
Anterior segment: ODS slight cortical opacities. 
Fundi OD: The optic disk was surrounded by an area of atrophy of pigment 
epithelium and choriocapillaris. A mottled aspect of the pigment 
epithelium was seen in the whole macular area. 
OS: Peripapillary atrophy as in the right eye. Large area of atrophy of 
pigment epithelium and choriocapillaris with good visibility of the 
choroidal vessels in the posterior pole. 
FAG OD: A radial configuration of small hypofluorescent spots encircled an 
area of granular hyperfluorescence in the posterior pole (Figure 35). 
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Figure 35. (Laz.). Right eye. Mottled hyperfluorescence in the macular area. Peripapillary atrophy. 
Figure 36. (Laz.) Left eye. Large area of atrophy of pigment epithelium and choriocapillaris. Peripapillary 
atrophy. 
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OS: Both atrophic regions demonstrated clear visibility of the choroidal 
vessels throughout all phases of the angiogram. In the late phases dye was 
leaking from the borders (Figure 36). 
ERG OD: a-wave -60 ц b-wave 35 ц 
OS: -60 ц 105 μV 
EOG OD: 1.33 
Lp/Dt OS: 2.00 
CV OD: Dichromatic red-green defect with the neutral zone in the red part of 
the spectrum. Diminished red-sensitivity; no scotopisation. 
OS: Dichromatic blue-yellow defect with extension to the green-blue 
zone. Diminished red sensitivity; no scotopisation. 
UO test OD: Normal. 
OS: Sector-shaped loss in the right upper quadrant. 
The patient was referred to the E.N.T. department in our hospital. On 
examination, an acquired disease appeared unlikely. The audiogram showed a 
perceptive hearing loss, probably of cochlear origin: Fletcher index 65 dB AD, 35 
dB AS. According to the E.N.T. specialist, this could be of a hereditary nature. 
Case II. Patient Vlem., female, date of birth: 18.03.31 
History: In 1982 the patient was referred to our clinic because of macular 
degeneration ODS. The patient had complained of a slight decrease in night vision. 
Her sense of hearing had been deteriorating for several years. She was also known 
to have a hypertrophic cardiomyopathy, but had no cardiac complaints and was not 
using any medication. Two of her four children had died from a cytochrome-
oxidase deficiency. 
Visual acuity: OD 1.0 corr. S-0.50 
OS 1.0 corr. S-0.50 
Anterior segment: ODS normal. 
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Figure 37. (Vlem.). Righi eye. Bean-shaped atrophy of pigment epithelium and choriocapillaris temporal to the 
fovea. 
Figure 38. (Vlem.). Left eye. Arterial phase with clearly visible choroidal vessels within the lesion and at the 
temporal border of the optic disk. 
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Fundi ODS: In both posterior poles a large, well-demarcated, bean-shaped 
atrophy of pigment epithelium and choriocapillaris was found at the 
temporal side of the fovea. Peripapillary atrophy was noticed in both 
eyes. Furthermore, the choroidal vessels in both fundi were quite 
prominent. 
FAG ODS: Increased visibility of the choroidal vessels in all phases of the 
angiogram. In the late phases, the lesions in the posterior pole, as well the 
peripapillary lesions, showed leakage of dye from their borders (Figures 
37 and 38). 
ERG OD: a-wave -25 pV b-wave 45 pV 
OS: -25 pV 45 ц 
EOG OD: 1.33 
Lp/Dt OS: 1.66 
CV OD: Blue-yellow defect, no diminished red-sensitivity. 
OS: Blue-yellow defect, protan accumulation in 100-Hue test, no 
anomaloscopic diminished red-sensitivity. 
From information obtained from her E.N.T. specialist, it was concluded that her 
audiogram had revealed a perceptive hearing loss, probably of cochlear origin: 
Fletcher index 75 dB AD, 70 dB AS. Visual acuity and the fundoscopic picture 
remained unchanged during a six-year follow-up period. In April 1991, she died 
from complications following severe pneumonia. 
77 
CHAPTER 4 
D I S C U S S I O N 
4.1 Clinical findings in central areolar choroidal dystrophy 
In this study, clinical findings for the largest group of patients suffering from 
central areolar choroidal dystrophy ever described, are presented. Thirty family 
members from seven families in which two or more generations were affected, and 
seven sporadic cases had been examined, with special attention to the stages of 
CACD preceding the atrophic end-stage. 
The age of the patients varied from twenty-two to sixty-eight years (Table 3). 
Male and female patients appeared equally affected (Table 2). Most of the patients 
with stage I or II were about 40 years of age or younger and did not suffer from 
visual complaints. No very young patients with obvious macular changes, as 
described by Carr (1965a), were encountered. 
Visual deterioration developed in patients in their mid-forties. Visual acuity in 
patients with stage III was in general only moderately affected to a level of 0.8 to 
0.6 (Table 4). Additional choriocapillaris atrophy, arising at this stage, led to 
paracentral scotomas, experienced as inconvenient by these patients. Reduced 
visual acuity in this group of patients occurred together with a red-green defect and 
a reduced central sensitivity in visual field testing, indicating that the central 
photoreceptors had already been affected to some extent at this stage. Vision 
dropped dramatically to a level below 0.1 when choriocapillaris atrophy affected 
the fovea and therefore led to a deeper central scotoma (stage IV). In general, this 
happened between the ages of fifty and seventy. 
The localization of choriocapillaris atrophy is very important in the 
development of deterioration of visual acuity in CACD. To determine atrophy of 
the pigment epithelium in the early two stages of CACD is, however, very 
important, as this finding can lead to a diagnosis of CACD. 
Atrophy of the pigment epithelium or atrophy of the choriocapillaris was not 
conspicuous in ophthalmoscopy or contact lens examination in two patients with 
stage I and four patients with stage III CACD respectively, but could clearly be 
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observed in fluorescein angiography. The first angiographic findings were small 
parafoveal window defects. In stage II the hyperfluorescent areas confluated 
around the fovea. Sometimes a radial configuration of hypofluorescent spots 
imitated a pattern dystrophy. 
The early phase of the angiogram is very important in detecting first signs of 
choriocapillaris atrophy, because leakage of dye from the borders may cover the 
choroidal vessels. 
Recorded electric potentials in the photopic electroretinogram were slightly 
reduced in about 50% of the patients in stages II to IV (Table 5). This indicated that 
some damage to the photoreceptors had already occurred in the posterior pole from 
stage II onwards. The electric potentials after 12 minutes of dark adaptation and the 
electro-oculographic values were in general normal, which meant that the damage 
to photoreceptors and pigment epithelium was confined to the posterior pole (Table 
5 and 6). Therefore I could not confirm Carr's suggestion (1965a), that this disease 
was probably more widespread. 
Colour vision tests (Table 7) and visual field tests (Table 8) are very helpful in 
diagnosing CACD, because abnormal results can be found even in stage I. 
A reduced red sensitivity with pseudoprotanomaly in colour vision tests and a 
reduced paracentral sensitivity in the visual field indicated some loss of 
photoreceptors in this area. When the paracentral scotoma became more obvious in 
stages II and III, a blue-yellow defect was observed in several patients. This 
corresponded to the paracentral atrophy noted in fluorescein angiography. 
However, in the majority of patients with stage III, a combined blue-yellow and 
red-green colour vision defect was noted, proving that the central photoreceptors 
had already become more affected at this stage than would be suspected from the 
atrophy noted on the fluorescein angiogram. Visual field tests showed a reduced 
central sensitivity or a central scotoma in 50% of the cases, confirming the results 
of the colour vision tests at this stage. 
There is no therapy available for CACD and it seems unlikely that one will be 
developed in the near future. Nevertheless, it is important to detect the early stages 
of CACD, because this diagnosis can exercise considerable influence on the future 
life of the patient. Earlier detection of the disease can lead to another choice of 
career, in which it is easier to practise with the handicap of a central scotoma. 
In young patients with a family history of CACD, but without visual 
complaints, hyperfluorescent parafoveal spots on the fluorescein angiogram 
suggests the probability of an early stage of CACD. The diagnosis can be 
supported by the presence of parafoveal reduced sensitivity and a reduced red 
sensitivity, pseudoprotanomaly or blue-yellow defect. 
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4.2 Staging of central areolar choroidal dystrophy 
Krill (1977) divided CACD morphologically into four stages, based on 
fundoscopic and angiographic changes during the course of the disease. The results 
of this study, comprising thirty-seven patients, make it possible to expand this 
classification regarding clinical and (electro-)physiological findings. The 
classification criteria are set out below: 
Stage I. The patients in this group are twenty to forty years old. There are no visual 
complaints and visual acuity is unaffected. Small alterations of the parafoveal 
pigment epithelium are barely visible with indirect ophthalmoscopy. Sometimes 
even with direct ophthalmoscopy or fundus examination by means of a 60-dioptres 
slitlamp lens, the delicate alterations are not evident (Figure 39). Only fluorescein 
angiography reveals the presence of small parafoveal, hyperfluorescent spots with 
the characteristics of window defects of the retinal pigment epithelium (Figure 40). 
EOG and ERG values are normal. A paracentral reduced sensitivity in the visual 
field tests and a diminished red sensitivity with pseudoprotanomaly in colour 
vision tests may indicate a slight disturbance in the parafoveal area. 
Stage II. The age of the patients in this stage varies from twenty to fifty. 
Occasionally visual complaints are noted together with slightly reduced visual 
acuity. Modest parafoveal hypopigmentation is already obvious in indirect 
ophthalmoscopy (Figure 41). Besides the mottled hyperfluorescence surrounding 
the fovea, fluorescein angiography may show a radial configuration of 
hypofluorescent spots. The radial configuration of these spots are more 
conspicuous in older patients suffering from this stage of CACD (Figure 42). The 
photopic ERG is abnormal in more than 50% of the eyes. EOG ratios are normal or 
slightly subnormal. Colour vision and visual field tests correspond with those seen 
in stage I. Occasionally an additional blue-yellow defect may be found. 
Stage III. Although the age of patients suffering from this stage may vary from 
twenty to seventy, most of them are older than forty years of age. In the majority of 
eyes, visual acuity is moderately reduced (0.8 - 0.3). The areas of atrophy of 
pigment epithelium and choriocapillaris are sometimes not visible with fundoscopy 
(Figure 43). To detect these atrophic patches in all patients, fluorescein 
angiography is imperative. Especially in the early phases, the visibility of the 
choroidal vessels is striking. Later the view on these vessels may be blocked by 
leakage of dye from the borders (Figure 44). The atrophy of the choriocapillaris 
seems to be secondary to the atrophy of the pigment epithelium. 
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Figure 39. Fundusphotograph of stage ICACD. Hardly detectable fundus alterations. 
Figure 40. Fluorescein angiogram as stage 1 CACD. Small hyperfluorescent spots nasally of the fovea. 
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Figure 41. Fundusphotograph of stage IICACD. Parafoveal hypopigmentations. 
Figure 42. Fluorescein angiogram in stage II CACD. Note radial configuration of hypofluorescent spots. 
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Figure 43. Fundusphotograph of stage III CACD. Area of atrophy of the choriocapillaris temporal to the fovea. 
Figure 44. Fluorescein angiogram in stage III CACD. Leakage from the borders in the late phase. 
CHAPTER 4 
Figure 45. Fundusphotograph in stage IV CACD. Demarcated area of atrophy of pigment epithelium and 
choriocapillaris. 
Figure 46. Fluorescein angiogram in stage IV CACD. Choroidal vessels are clearly visible. 
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The photopic ERG sometimes indicates a generally reduced cone function. Dark 
adaptation and EOG values may be subnormal. In colour vision tests, a red-green 
defect often indicates that besides the parafoveal area, the fovea has also become 
affected in these eyes. A central scotoma or reduced central sensitivity confirms the 
outcome of these tests. 
Stage Г . The ages of the patients in this group range from forty to seventy years. In 
general, visual acuity is less than 0.1. The area of atrophy of pigment epithelium 
and choriocapillaris can clearly be noticed on fundoscopy by its golden-yellowish 
appearance (Figure 45). The former area of pigment epithelium atrophy is partially 
or totally affected by subsequent choriocapillaris atrophy. The latter picture is the 
end-stage or final stage of CACD, which is characterized by a round atrophic 
lesion in the posterior pole, not connected to the optic disk and with clear visibility 
of the choroidal vessels. The angiographic picture resembles that seen in the 
atrophic lesions of stage III (Figure 46). However, in very advanced cases, 
additional atrophy of the smaller choroidal vessels, the precapillary arterioles, can 
be noticed. ERG and EOG values are similar to those in stage III. In colour vision 
and visual field tests a red-green and blue-yellow defect and a central scotoma are 
usually encountered. 
Indocyanine green video-angiography was performed on one patient with stage 
I CACD. It showed that choriocapillaris atrophy was possibly to some extent 
already present at this stage. 
Because this has been the only case published up to the present, and because 
experience in this technique is still limited, one has to be careful in drawing 
conclusions, but this may be a helpful additional tool in detecting early stages of 
CACD in future. 
In several cases with a stage III CACD, colour vision tests and visual fields 
indicated that the central photoreceptors had already become affected. However, 
because visual acuity was only moderately affected in these patients, they should 
possibly not be regarded as stage IV. This stage should be restricted to cases in 
which choriocapillaris atrophy of the fovea led to low visual acuity. It could be 
regarded as the end-stage of CACD. 
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4.3 Differentiation between central areolar choroidal dystrophy 
and other dystrophies of the posterior pole 
Differentiation of CACD from other macular diseases that give rise to 
chorioretinal atrophy, can be done by carefully comparing the history, course 
of the disease, ophthalmic examination, fluorescein angiography and (electro)-
physiological examination. 
The mode of transmission of a particular chorioretinal atrophy is, by itself, not of 
much use, because CACD can be inherited autosomal-dominantly and recessively. 
However, it can be taken into account with other characteristics. Central areolar 
pigment epithelial (CAPE) dystrophy, Best's vitelliform dystrophy, Sorsby's fundus 
dystrophy, North Carolina macular dystrophy and benign concentric annular macular 
(BCAM) dystrophy are always autosomal-dominantly inherited. When cone and 
adult vitelliform dystrophies are familial, this is the most common pattern of heredity. 
Autosomal-dominant transmission has been described on occasion with regard to 
Stargardt's disease and age-related macular degeneration (ARMD). In general, 
Stargardt's disease is autosomal-recessively inherited. Juvenile atrophy of the retinal 
pigment epithelium and choriocapillaris also seems to be inherited in this way. Cone 
dystrophies are the only choroidal atrophies of the posterior pole that may be 
inherited in an x-linked way. Serpiginous choroiditis only occurs sporadically. 
ARMD, cone dystrophies and macular colobomata normally occur sporadically, 
while the latter disease is often accompanied by other ocular or non-ocular diseases. 
The age of onset of complaints and/or symptoms is very important in the 
differentiation of the various diseases. In patients with CACD, the first visual 
complaints usually develop in the patients' mid-forties. Juvenile atrophy of the retinal 
pigment epithelium and choriocapillaris, macular colobomata and North Carolina 
macular dystrophy are present at birth. Most cases of Best's vitelliform dystrophy, 
cone dystrophies and Stargardt's disease present with symptoms before the third 
decade. Patients with serpiginous choroiditis, Sorsby's fundus dystrophy and adult 
vitelliform dystrophy often are middle-aged when they first experience reduced 
visual acuity, accompanied by central chorioretinal atrophy. CAPE dystrophy, North 
Carolina dystrophy and benign concentric annular macular dystrophy frequently do 
not affect vision at all, or only in older patients. ARMD affects older patients. 
Decrease of visual acuity depends on the degree of atrophy of the central 
photoreceptors. These are only a little affected in stage III of CACD, the vitelliform 
dystrophies, CAPE dystrophy, North Carolina dystrophy and BCAM dystrophy, and 
vision acuity is therefore only slightly reduced in general. When the central 
photoreceptors are severely affected, visual acuity is usually lower than 0.1. 
This applies to stage IV of CACD, ARMD, Stargardt's disease, progressive cone 
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dystrophy, juvenile atrophy of the pigment epithelium and choriocapillaris, macular 
colobomata, Sorsby's fundus dystrophy and serpiginous choroiditis with macular 
involvement. 
In stage IV of CACD, a demarcated atrophy of retinal pigment epithelium and 
choriocapillaris is seen in fundoscopy. In several other dystrophies this kind of 
atrophy is accompanied by other features. Drusen will often be noted around the 
macular lesion in ARMD. In Stargardt's disease the characteristic 'fish-tail' flecks 
can be spotted around the atrophic area. In juvenile atrophy the central lesion is 
connected to a small optic disk. Compared to the atrophy in CACD, the atrophy in 
cone and vitelliform dystrophies is smaller and more circular in shape. In macular 
colobomata and North Carolina dystrophy the number of choroidal vessels is 
severely reduced, while in the latter disease the lesion is surrounded by drusen-like 
spots. Serpiginous choroiditis has more irregularly shaped lesions with areas of 
hyperpigmentation. In Sorsby's fundus dystrophy, pale fundus spots surround the 
lesion. In BCAM and CAPE dystrophy, the areas of choroidal atrophy are situated 
parafoveally and may resemble stage III CACD. In BCAM dystrophy bone 
spicules-like hyperpigmentation has been reported. 
Fluorescein angiography can give additional information with regard to the 
differentiation of atrophic central lesions. In Stargardt's disease the area of atrophy 
is often surrounded by an area of hypofluorescence of the choroid, the so-called 
'dark choroid'. Early hyperfluorescent spots with leakage of dye may reveal 
subretinal neovascularisation in Best's vitelliform dystrophies, serpiginous 
choroiditis and Sorsby's fundus dystrophy. Active areas in serpiginous choroiditis 
appear hypofluorescent in fluorescein angiography. 
Photopic and scotopic electroretinograms (ERG) prove normal or subnormal in 
advanced cases of CACD. In cone dystrophy, the photopic ERG shows reduced or 
absent responses. In BCAM dystrophy, the photopic and scotopic responses may be 
slightly or grossly reduced. Cases of macular colobomata with extinguished ERG 
responses have also been reported. 
Electro-oculograms (EOG) are normal in CACD. They are reduced in Best's 
vitelliform dystrophy. 
Colour vision test results in CACD often change from revealing a blue-yellow 
defect in stage III, to revealing a combined red-green, blue-yellow defect in stage 
IV. In cone dystrophy, Stargardt's disease and Best's vitelliform dystrophy, a red-
green defect is already present in the early stages of the disease. 
The typical clinical presentation of autosomal-dominantly inherited CACD, 
together with its mode of transmission, should make it not too difficult to 
differentiate it from other macular dystrophies. In older patients without a family 
history of CACD, differentiation between the atrophic stages of ARMD or 
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Stargardt's disease and a sporadic case of CACD may be troublesome, especially 
when associated evidence like drusen (ARMD) or flecks and dark choroid 
(Stargardt's disease) are not evident. In these cases the age of onset of visual 
deterioration is conclusive. Therefore, if the only evidence in an elderly patient is a 
demarcated area of atrophy of the pigment epithelium and choriocapillaris in the 
posterior pole in fundoscopy and fluorescein angiography, together with a red-
green and blue-yellow colour vision defect, and other (electro-)physiological 
findings are normal, one should try to establish the age of onset of the symptoms 
and visual complaints. Sometimes it may be necessary to retrieve information from 
ophthalmologists patients visited in the past. 
4.4 Central areolar choroidal dystrophy and perceptive hearing loss 
In chapter 3.15, the case history of a man and a woman, both of whom 
experienced a simultaneous and gradual loss of vision and hearing commencing in 
their mid-forties, is reported. Visual acuity was slightly to moderately reduced in 
the male and not affected in the female patient. A demarcated area of atrophy of 
pigment epithelium and choriocapillaris around the optic disk and in the posterior 
pole, with sparing of the fovea, was observed in both eyes of the patients. ERG and 
EOG values in the right eye of the first and in both eyes of the second patient were 
subnormal. Colour vision tests were in accordance with the locality of the lesions. 
In both patients, a severe perceptive hearing loss was diagnosed, which could not 
be explained as resulting from an acquired disease. 
The atrophic lesion found in the left eye of the first and in both eyes of the 
second patient, may indeed suggest CACD as it has been reported in previous 
studies by various authors (Sandvig, 1959; Deutman, 1971; Carr et al., 1975). The 
granular atrophy of the retinal pigment epithelium with a radial configuration of 
hyperpigmented spots has been observed by the author in a woman suffering from 
a stage II CACD (fam. Gu. Ill-17). It is therefore considered that a diagnosis of 
CACD is the most likely and accurate for these fundus lesions. It is, however, 
remarkable that - although none of the patients was myopic - a peripapillary 
atrophy of pigment epithelium and choriocapillaris was noticed in both of them. 
Until now several reports have been compiled about abnormalities in the 
posterior pole of the eye in combination with deafness. Chorioideremia has been 
described together with obesitas and congenital deafness as an x-linked transmitted 
disorder in a family of three generations (Ayazi, 1981). 
Hansen reported a familial syndrome of progressive cone dystrophy, hearing 
defects, pathological glucose tolerance, diabetes, liver disease and endocrinological 
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disturbances (Hansen et al., 1976). The facio-oculo-acousticorenal (FOAR) 
syndrome is characterized by a variety of ocular abnormalities such as telecanthus, 
iris stromal hypoplasia, iris coloboma, posterior synechiae, heterochromia and 
retinal detachment. In one patient extensive choroidal atrophy has also been 
reported (Regenbogen and Coscas, 1985). Central areolar choroidal dystrophy in 
three brothers from a family with pseudo-achrondroplastic spondyloepiphyseal 
dysplasia was described by Mansour in 1987 (Mansour, 1987). Deutman reported a 
60-year old man with acute poliomyelitis and acute rheumatism, in whom he found 
an early stage of CACD (Deutman, 1971). 
Although it is possible that this combination of central areolar choroidal 
dystrophy and perceptive hearing loss may be a coincidence, the almost identical 
findings in our patients are regarded as significant enough to warrant their 
inclusion as a possible separate clinical entity. However, it is too early to present 
these ocular and auditory abnormalities as an obvious oculo-auditory syndrome; 
more cases should be investigated before a conclusion can be reached. 
4.5 Genetic aspects 
Familial cases, mode of transmission 
In the chapter on family studies, seven pedigrees were described in which 
transmission of CACD from a parent to one or more children over at least two 
generations had been established. In these pedigrees, eight (fam. Gu.), seven (fam. 
Ja.), two (fam. Si), three (fam. Sta.), four (fam. Te.), three (fam. Ho.) and three 
(fam. Li.) siblings were respectively affected (Table 1, appendix II). Affected or 
reputedly affected siblings were found over two (fam. Si., fam. Li.), three (fam. Ja., 
fam. Sta., fam. Ho.) or four generations (fam. Gu., fam. Te.) of one sibship. 
Sandvig (1955) was the first to report CACD in four generations of one family, 
and therefore stated that there was conclusive evidence for an autosomal-dominant 
mode of heredity. Since his publication, only four other families have been reported 
(Franceschetti, 1963a; Carr, 1965a; Noble, 1977; Hutter and Marquardt, 1989). 
Hutter noted transmission over three generations. Because of this low number of 
familial cases in literature, it seems reasonable to test our pedigrees against the 
hypothesis of autosomal-dominant transmission. 
Because in CACD complaints about a loss of vision develop from the ages of 
about thirty to fifty, the generations in which visual impairment is to be expected must 
be scrutinized, in order to determine how many siblings in one sibship are affected. 
Family Si. will not be taken into account, because none of the relatives of the 
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older generations of patient Si. II-1 have been known to have a visual handicap. 
Two deceased siblings of family Sta. will not be taken into account, because they 
died young. This leaves forty-four siblings in six pedigrees: generation III in fam. 
Gu., II in fam. Ja., II in fam. Sta., Ill in fam. Te., II in fam. Ho. and II in fam. Li. In 
these generations, siblings younger than fifty-five years of age were examined. 
They were at 50% prior risk assuming autosomal-dominant inheritance. Since 
twenty-two of these forty-four (eleven males and eleven females) indeed proved 
affected, these data proved fully compatible with autosomal-dominant heredity, 
with complete penetrance from the age of 50. 
In x-linked transmitted diseases, an affected male can only inherit the disease 
from his mother, who is a carrier. In this study, transmission from father to son was 
encountered in two families (fam. Ja., fam. Ho.). This excludes an x-linked mode 
of heredity. 
In all families, affected members were found to occur over two generations. 
Reputed affected members were reported in one (fam. Ja., fam. Sta., fam. Ho.) and 
more (fam. Gu., fam. Te.) older generations. (The phrase 'reputedly affected' is 
used to describe family members who were known to have a central scotoma from 
their middle age and were therefore visually disabled, but not blind.) For the 
reasons mentioned above, an autosomal-dominant pattern of heredity is very 
probable. In family Si., the index patient II-1 most likely carries a new autosomal-
dominant mutation. 
Familial cases, penetrance 
CACD develops slowly during the first decades of life, without giving rise to 
visual complaints. The age-dependent penetrance is the ratio between the number of 
symptomatic patients in a certain age category and the number of total gene carriers 
in that category. This means, that in an autosomal-dominant transmitted disease with 
a penetrance of 100%, all of the gene carriers of one generation, which are 50%, are 
indeed affected. In CACD this applies to the siblings older than fifty years of age. 
Because in families with CACD, young individuals carrying the gene may still be 
asymptomatic, the age-related penetrance has to be calculated, in order to determine 
how many affected siblings can be expected in a certain age group. The age group 
of twenty to forty years was selected for this purpose, because no affected patients 
younger than twenty years of age were encountered, and because almost all 
symptomatic patients older than forty years of age had visual complaints. Thirty-six 
members aged between twenty and forty, from seven families, were examined. On 
the basis of autosomal-dominant heredity, with a 100% penetrance, the expected 
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number of symptomatic cases would be eighteen. However, nine members were 
found to be affected. This means that an age-dependent penetrance of approximately 
50% (9/18) was established for the age group of twenty to forty years. 
It has to be noted that eight persons among the asymptomatic group were only 
examined at home with indirect and direct ophthalmoscopy and refused further 
examination in our clinic. Despite the fact that direct ophthalmoscopy is a very 
valuable method in detecting small pigmentary alterations, contact-glass 
examination and fluorescein angiography could possibly have led to the detection 
of more affected family members. The proportion of apparently asymptomatic gene 
carriers in this age group may therefore be somewhat reduced. 
Families in which autosomal-dominant inheritance could not be established 
As noted before, the natural course of CACD in sporadic cases is similar to the 
development in familial cases. Various findings such as age of onset, fundoscopic 
and angiographic picture, argue against designating these cases as an age-related 
macular degeneration (ARMD). 
In none of the families of our patients consanguinity was known. Furthermore, 
affected members of the same sibship could not be established in the case of six 
patients. In these cases it is not possible to prove an autosomal-recessive pattern of 
heredity, but at the same time it can not be rejected out of hand. Another possibility 
would be autosomal-dominant mutation or a non-genetic disease. Additional factors, 
either genetic or environmental, may be important in the presentation of CACD in 
some cases (Heckenlively, 1988). In previous studies, isolated patients with CACD, 
in whom neither consanguinity nor other affected members of one sibship could be 
proven, have been described (Sandvig, 1959; Deutman, 1971; Carr et al., 1975; 
Noble, 1977; Zrenner et al., 1986). Our patients resemble these in age of onset, 
fundoscopic picture, angiographic and (electro)-physiological findings. 
In the case of one female patient (Jan.), a brother was also affected. As a matter 
of fact, this patient could also have been listed in the family studies, but as had been 
mentioned, this group was restricted to families with affected siblings in two or 
more generations. In this case autosomal-recessive heredity or germline mosaicism 
for dominant mutation could be possible. 
Sorsby (1935), Sorsby and Crick (1953) reported four families with CACD in 
two or more siblings bom to unaffected parents, while no other family members 
were affected. This patient (Jan.) is similar to the sporadic cases in whom Sorsby 
proved the hereditary nature of this disease. 
Future research should be aimed at the localization and subsequent isolation and 
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examining of the gene or genes responsible for the natural course of CACD. 
Because the possibility of localization increases with the number of affected and 
unaffected siblings in one pedigree, large families (fam. Gu., fam. Ja.) are most 
suitable for this investigation. With a better understanding of the early stages of 
CACD in patients without visual complaints, it will be possible to trace more family 
members in whom fundus changes will probably be noted several years after our first 
examination. 
A biochemical defect is as yet unknown in CACD and therefore the traditional 
way of gene-localization, so-called 'functional cloning', appears unsuitable for this 
investigation. 'Positional cloning' would appear to be preferable. In this method 
polymorph markers are used, which are spread over the genome. By comparing the 
heredity of the mutation leading to CACD with these polymorph markers, the gene 
sequence, that is always inherited together with the mutation, can be observed. 
This is called 'linking'. Because the localization of the polymorph markers is 
known in the genome, it is possible to determine in which chromosome the mutation 
is located. Afterwards, one can look for the mutation in the genes present in this 
chromosome. This method has lead to the isolation of the responsible genes in various 
ophthalmic diseases like choroideremia, Nome's disease, aniridia and several forms 
of retinitis pigmentosa. 
Just recently, mutations in the retinal degeneration slow ('rds') gene have been 
implicated as a cause of macular dystrophy. This autosomal-dominant dystrophy, 
that was found in three sibships, closely resembles CACD with the only exception 
that the cone functions in the electroretinogram in these patients are perhaps more 
decreased (Wroblewski et al., 1994). However, it would be interesting to look for 
these mutations in our families. 
To conclude, it can be said that most families with CACD show autosomal-
dominant heredity with complete penetrance from about the age of forty to fifty. 
Isolated cases clinically resemble familial cases in every respect, suggesting they 
may be due, at least in part, to new autosomal-dominant mutations. Affected 
siblings bom to unaffected parents could represent an autosomal recessive 
subgroup, but the absence of parental consanguinity testifies against this 
hypothesis. Another possibility is germline mosaicism for an autosomal-dominant 
mutation in one of the parents. 
Follow-up of these families could confirm this hypothesis if offspring of 
isolated cases are also found to have CACD. 
There is no convincing evidence for genomic imprinting, because the disease, 
although variable to some extent, runs a similar course when inherited from father 
or mother. 
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Summary of the clinical findings in 30 patients from 
7 families and 7 sporadic cases 
Clinical findings in the 7 families 
patient 
Gu III-l 
OD 
OS 
Gu III-3 
OD 
OS 
Gu Ш-7 
OD 
OS 
Gu III-9 
OD 
OS 
III 12 OD 
OS 
Gu III 13 
OD 
OS 
sex 
F 
F 
M 
M 
F 
M 
Age 
AoC 
56 
52 
64 
46 
47 
37 
46 
42 
52 
52 
42 
VA 
0 8 
0 8 
cf lm 
cflm 
0 6 
0 1 
1 
c f lm 
0 1 
c f lm 
0 16 
cf0 5 
m 
spheq 
175 
175 
-0 25 
1 5 
-0 5 
0 
0 
0 
AS 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
Fundus 
granular 
hypopigmentaüon 
except fovea 
rpe, chonocap 
atrophy except fovea 
end-stage CACD 
as OD 
rpe, chonocap 
atrophy around 
fovea 
end-stage CACD 
granular 
hypopigmentation 
around fovea 
end stage CACD 
rpe, chonocap 
atrophy around the 
fovea 
end-stage CACD 
end stage CACD 
as OD 
FAG ERG 
(uV) 
rpe and chonocap atrophy a 60 
except fovea b 100 
rpe, chonocap atrophy except a -60 
fovea Hypofluorescence along b, 100 
border 
a 30 
b 50 
a -20 
b 40 
patches of chonocap atrophy a 70 
around fovea b 60 
hypofluorescent spots around a -70 
lesion b 60 
granular hypopigmentation a -60 
around border b 60 
as OD a -70 
b 70 
DA 
(uV) 
160 
160 
140 
160 
180 
170 
240 
280 
EOG 
lp/Dt 
193 
193 
6 64 
5 5 
1 51 
2 42 
28 
187 
CV 
r-g defect and b 
defect 
as OD 
r g and b y 
defect, 
diminished red 
sensitivity, 
scotopization 
as OD 
r-g, b-y defect 
as OD 
г g, b y defect 
as OD 
Vis field stage 
y III 
III 
rv 
rv 
kinetic annular scotoma III 
within 2-1, relative 
central scotoma within 
4 1 isopter 
as OD Г 
III 
Г 
III 
rv 
rv 
rv 
Clinical findings in the 7 families 
patient 
GuIII-17 
OD 
OS 
Gu IV-45 
OD 
OS 
Ja II-1 
OD 
OS 
Ja II-4 
OD 
OS 
Ja II-5 
OD 
OS 
Ja II-7 
OD 
OS 
Ja II-8 
OD 
OS 
Ja III-3 
OD 
OS 
JaIII-9 
OD 
OS 
Si II-3 
OD 
OS 
sex 
F 
M 
M 
F 
M 
F 
M 
M 
M 
F 
age 
46 
20 
61 
62 
52 
60 
45 
57 
47 
56 
46 
28 
22 
56 
45 
VA 
1 
1 
1 
1 
0.8 
0.6 
c f lm 
cf lm 
cf3m 
cf 3m 
cf lm 
cf lm 
cf lm 
c f lm 
1 
1 
1 
1 
0.4 
0.4 
sphe.eg 
ÍP) 
0 
0 
-3 
-4 
2.5 
2.5 
-1.25 
-1 
0.25 
0 
0.25 
0.25 
A.S 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
Fundus 
mottled 
hypopigmentation 
around fovea 
as OD 
hypopigmentation 
around fovea 
as OD 
rpe, choriocap. 
atrophy nasally of 
the fovea 
as OD 
end-stage CACD 
as OD 
end stage CACD 
as OD 
end-stage CACD 
end-stage CACD 
end-stage CACD 
as OD 
slight parafoveal 
hypopigmentation 
as OD 
FAG 
granular hypofiuorescence 
in radial configuration 
as OD 
mottled hyperfluorescence 
around fovea 
as OD 
hypofiuorescence around 
the lesion 
as OD 
small hyperfluorescent spot 
around fovea 
as OD 
ERG 
i«V) 
a: -80 
b:80 
a: -90 
b:90 
a: 
b: 
a: 
b: 
doubtfull parafoveal slight hyperfluorescent spots 
hypopigmen tarions 
as OD 
granular 
hypopigmentation 
of the macula 
as OD 
around fovea 
as OD 
parafoveal patches of 
choriocap. atrophy 
as OD 
a: 
b: 
a: 
b. 
-70 
140 
-80 
150 
-40 
150 
-35 
100 
DA EOG 
fuVl lo/Dt 
310 
300 
210 
360 
390 
380 
2.22 
1.97 
2.29 
1.78 
3.42 
3.46 
CV 
normal 
normal 
normal 
normal 
r-g defect, 
pseudoprotanomaly 
as OD 
Vis.field 
UO: normal 
UO: ringscotoma 
stage 
II 
II 
II 
II 
III 
III 
Г 
rv 
Г 
rv 
rv 
rv 
rv 
rv 
I 
I 
1 
I 
III 
III 
Clinical findings in the 7 families 
patient 
SiIII-1 
OD 
OS 
Sta II-1 
OD 
OS 
Sta II 5 
OD 
OS 
Sta III 1 
OD 
OS 
Te III 3 
OD 
OS 
Te III 4 
OD 
OS 
Te III 5 
OD 
OS 
sex 
F 
F 
F 
F 
M 
M 
F 
Age 
AoC 
22 
68 
31 
57 
50 
35 
64 
63 
55 
62 
58 
VA 
1 
1 
0 1 
0 1 
0 125 
cf lm 
1 
1 
0 3 
0 4 
cf2m 
0 125 
06 
0 8 
spheq 
(D) 
0 
0 
0 
0 
0 
0 
0 
0 
0 25 
0 25 
4 
5 
10 5 
8 5 
AS 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
π 
η 
η 
Fundus 
seemed normal 
slight parafoveal 
hypopigmentations 
end stage CACD 
as OD 
end stage CACD 
rpe atrophy 
slight 
hypopigmentations 
under fovea 
as OD 
rpe atrophy and 
parafoveal patches о 
chonocap atrophy 
as OD 
end stage CACD 
as OD 
granular 
hypopigmentation с 
the macula 
as OD 
FAG 
slight hyperfluorescent spots 
ERG 
(uV) 
a -50 
around the fovea Indocyanine b 110 
green videoangiography, see 
chapter 2 11 
slight parafoveal 
hyperfluorescent spots 
atrophy of smaller choroidal 
vessels 
as OD 
atrophy of smaller choroidal 
vessels 
only late phase, chonocap 
seems also atrophic 
hypo and hyperfluorescent 
spots around the fovea 
as OD 
f 
hyperfluorescence of fovea 
f and parafoveal area surround« 
by hypo and 
hyperpigmentation 
as OD 
a 80 
b 140 
a -70 
b 130 
a 60 
b 120 
a 70 
b 100 
a 70 
b 90 
a 30 
b 150 
a 50 
b 170 
a 70 
b 60 
a 70 
b 70 
DA 
(uV) 
280 
280 
220 
170 
300 
300 
200 
250 
200 
180 
EOG 
lp/Dt 
3 25 
3 14 
2 67 
2 26 
1 24 
1 16 
2 96 
3 32 
1 7 
176 
CV 
normal 
normal 
r-g,b у defect 
as OD 
pseudoprotanom 
aly 
as OD 
sensitivity 
decrease with 
anomaloscope 
diminished red 
sensitivi tv 
as OD 
Vis field 
staue normal 
as OD 
UO normal, static 
parafoveal reduced 
sensitivi tv 
as OD 
kinetic reduced central 
sensitivity within I 1 
isopter 
as OD 
stage 
I 
I 
rv 
rv 
rv 
rv 
I 
I 
III 
III 
rv 
rv 
II 
II 
Clinical findings in the 7 families 
patient 
TeIV-10 
OD 
OS 
Но Ш-2 
OD 
OS 
HoIII-1 
OD 
OS 
Но Ш-2 
OD 
OS 
Li III-2 
OD 
OS 
sex 
F 
M 
M 
F 
F 
Age 
AoO 
26 
25 
56 
54 
32 
28 
53 
VA 
0 5 
1 
0 6 
0 6 
1 
1 
0 8 
1 
0 25 
0 25 
spheq 
(D) 
-6 
-6 5 
-1 
1 5 
-1 75 
1 25 
0 75 
0 75 
0 5 
0 25 
AS 
η 
η 
η 
η 
η 
η 
η 
η 
η 
η 
Fundus 
hypopigmentations 
in the macula 
hypopigmentations 
under fovea 
granular 
depigmentation in 
the macula 
as OD 
granular 
depigmentation 
parafoveally 
as OD 
granular 
depigmentations in 
the macula 
as OD 
granular 
FAG 
parafoveal patches of 
chonocap atrophy with 
leakage of dye in late phase 
hypofluorescent spots 
encircling the fovea 
patches of atrophy of rpe and 
chonocap 
as OD 
parafoveal mottled hypo and 
hyperfluorescence 
as OD 
hypofluorescence of the fovea 
surrounded by mottled hypo 
and hyperfluorescence 
as OD 
areas of chonocap atrophy 
hypopigmentation of leak during the late phase 
the macula with 
atrophy of 
chonocap under th< 
fovea 
granular as OD 
hypopigmentation of 
the macula, 
chonocap atrophy 
temnoral of fovea 
ERG 
(uV) 
a 50 
b 105 
a -50 
b 115 
a 40 
Ь60 
a 50 
b 50 
a-50 
b 60 
a 50 
b 60 
a -60 
b 140 
a -60 
b 120 
a 40 
b 110 
a 60 
b 140 
DA 
(uV) 
90 
120 
120 
120 
90 
90 
180 
230 
220 
250 
EOG 
lp/Dt 
2 
2 
2 17 
176 
1 8 
17 
1 9 
2 
1 66 
1 7 
cv 
slight b-y defect 
with diminished 
red sensitivity 
slight b-y defect 
with 
pseudoprotanom 
alv 
dichromatic b-y 
defect with 
neutral zone in 
Durole-blue 
as OD 
b у defect, 
pseudoprotanom 
aly 
pseudoprotanom 
alv 
normal 
normal 
r g,b у defect anc 
reduced red-
sensitivity 
as OD 
Vis field 
UO small central 
scotoma 
UO normal 
decreased sensitivity in 
pericentral area within I-
3,2 and 1 isopter 
as OD 
UO pericentral scotoma 
static reduced parafovea 
sensitivity 
UO annular scotoma, 
static as OD 
UO normal, static 
reduced parafoveal 
sensitivity 
UO decrease in plate 5 
and 6, static as OD 
static general reduced 
sensitivity, central 
scotoma, relative 
paracentral scotoma 
general reduced 
sensitivity, central 
scotoma 
stage 
III 
II 
III 
III 
II 
II 
II 
II 
III 
III 
Clinical findings in the 7 families 
patient 
Li Ш-3 
OD 
OS 
Li III-4 
OD 
OS 
sex 
M 
M 
Age VA 
AoO 
46 0 6 
43 
c f lm 
43 1 
1 
sph eq 
5 25 
-4 
0 
0 
AS 
η 
η 
η 
η 
Fundus 
atrophy of rpe and 
FAG 
leakage of dye in the late phase 
chonocap under the from the borders of the lesion 
fovea 
end-stage CACD 
granular 
hypopigmentation ir 
the macula 
hypopigmentations 
in the macula, 
chonocap atrophy 
under the fovea 
atrophy of smaller choroidal 
vessels 
hyperfluorescence with 
hypofluorescence around the 
border of the lesion 
circumscript area of 
chonocap atrophy under the 
fovea 
ERG 
(uV) 
a -30 
b 70 
a -20 
b 40 
DA 
(uV) 
265 
275 
EOG 
lp/Dt 
2 25 
2 
182 
153 
CV 
dichromatic b-y 
defect with 
slightly reduced 
red-sensitivitv 
dichromatic b-y 
defect, 
pseudoprotanom 
aly with r g 
defect 
Vis field 
static general reduced 
sensitivity, relative 
central scotoma with 
paracentral maximum 
as OD 
stage 
III 
IV 
11 
III 
Clinical findings in the 7 sporadic cases 
patient 
Clae 
OD 
OS 
Vors 
OD 
OS 
Troa 
OD 
OS 
Kell 
OD 
OS 
sex 
F 
M 
F 
F 
Age 
AoO 
52 
49 
48 
47 
39 
29 
51 
49 
VA 
1 
0 6 
1 
0 8 
08 
0 8 
08 
0 6 
sph eq 
(D) 
0 5 
1 5 
0 75 
0 75 
0 25 
-1 
0 25 
0 75 
AS 
η 
η 
π 
η 
η 
η 
η 
η 
Fundus 
granular 
hypopigmentation, 
atrophy of 
FAG 
mottled hyperfluorescence, 
leakage of dye in late phase 
from borders of area with 
choriocap temporal chonocap atrophy 
of the fovea 
area of choriocap 
atrophy next to the 
fovea, several drusen 
central area of rpe 
and choriocap 
atrophy except fovea 
as OD 
two areas of rpe and 
choriocap atrophy 
around fovea 
as OD 
demarcated area of 
rpe atrophy and 
granular atrophy in 
rest of macula 
as OD 
as OD 
circumscript area of rpe, 
chonocap atrophy temporal 
of fovea, mottled 
hyperfluorescence in rest of 
macula 
fovea enclosed by two areas ol 
rpe, choriocap atrophy 
small hyperfluorescent spots 
connect areas of rpe and 
choriocap atrophy 
as OD 
atrophy of rpe and chonocap 
ERG 
(uV) 
a -90 
b 80 
a 100 
b 110 
a 50 
b 30 
a -40 
b 40 
a 60 
nasally of the fovea, leakage of b 155 
dye from borders in late phase 
rpe, choriocap atrophy 
encirhng fovea 
a 65 
b 140 
DA 
(uV) 
150 
140 
170 
170 
375 
365 
EOG 
lp/Dt 
18 
17 
2 2 
2 03 
2 
1 94 
2 64 
2 
CV 
b-y and r-g 
defect, 
diminished red 
sensitivity 
as OD 
normal 
mild b y atrophy 
r-g and b y defec 
as OD 
b y and r g 
defect, 
pseudoprotanom 
alv 
dichromatic b-y 
defect, neutral 
zone in purple 
blue, 
pseudoprotanom 
aly, start of 
scotopization 
Vis field 
kinetic· relative central 
scotoma within I 2 
isopter 
as OD 
UO normal 
UO haziness in plate 5 
and 6 
static, relative central 
scotoma 
as OD 
static absolute temporal 
scotoma, relative 
paracentral scotoma 
static absolute scotoma 
temporal and under 
fovea, general decreased 
sensitivity 
stage 
III 
III 
III 
III 
III 
III 
III 
III 
Clinical findings in the 7 sporadic cases 
patient 
Wyn 
OD 
OS 
Jan 
OD 
OS 
Knip 
OD 
OS 
sex 
M 
F 
M 
Age 
AoO 
44 
43 
60 
32 
50 
45 
VA 
1 
0 4 
0 08 
0 08 
0 8 
0 8 
sph eq 
(D) 
4 25 
4 5 
3 
2 25 
15 
1 25 
AS 
η 
η 
η 
η 
η 
η 
Fundus 
hypopigmentaüon 
around fovea 
rpe, chonocap 
atrophy nasally of 
the fovea 
end stage CACD 
as OD 
rpe, chonocap 
atrophy nasally of 
the fovea, 
hypopigmentations 
in rest of macula 
rpe, chonocap 
atrophy above the 
fovea 
FAG 
mottled hyperfluorescence 
around fovea 
leakage from borders in late 
phase from borders of 
atrophic lesion, mottled rpe ir 
rest of macula 
atrophy of smaller choroidal 
vessels, leakage of dye from 
borders in late phase 
as OD 
leakage from the border of 
atrophic lesion in late phase, 
mottled hyperfluorescence in 
rest of macula 
as OD 
ERG 
(uV) 
a 45 
b 75 
a -40 
b 75 
a 70 
Ы 2 0 
a 70 
b 120 
a 110 
b 150 
a 80 
b 105 
DA 
(uV) 
275 
265 
120 
80 
300 
270 
EOG 
lp/Dt 
2 38 
2 
143 
147 
2 
175 
CV Vis field 
b y and r g defect normal 
as OD 
r g and b y 
defect, 
diminished red 
sensitivi tv 
paracentral scotoma in 
plate 1 
r g and b y defect 
r g and b y 
defect, 
diminished red 
sensitivity, 
scotoDization 
as OD, but no 
scotopization 
UO paracentral scotoma 
in plate 4 
UO normal 
stage 
II 
III 
rv 
rv 
III 
III 
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Pedigrees of the 7 families 
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Figure II-1. Pedigree of family Си. 
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Figure 11-3. Pedigree of family Si. 
i 
III 
IV 
0 0 Ó O G 
:: 
G Ô О 
ù Ò G Ô 
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103 
0J& β β 0 
Ο Ο ßjO , » j Q ßh^ 
IV 
: j a ô ô ù ô ô u o û 
A¿ examined 
• φ affected 
Ξ © reputedly äff. 
0 0 dead 
' proband 
Figure //-5. Pedigree of family Te. 
LL 
III 
:: :; :: 
D Ô 
Figure II-6. Pedigree of family Ho. 
104 
APPENDIX Tl 
&T0 
III 
IV 
H »J 
D Ò D O 
Figure 11-7. Pedigree of family Li. 
105 
References 
AnmarkradN. (1978) 
Fundus fluorescein angiography in fundus flavimaculatus and Stargardt's disease. Acta Ophthalmol. 57:172-182. 
Amzallag В., Puech В., Hache J.C. and P. François ( 1990) 
Dystrophie progressive des cones: altérations électrophysiologiques chez le femmes transmettrices. J Fr. Ophtalmol 
13,8/9:421-428. 
Archer D., Krill A.E. and F.W. Newell (1969) 
Fluorescein studies of normal choroidal circulation. Am. J Ophthalmol. 69: 543-554. 
Archer D.B., Krill A.E. and F.W. Newell (1971) 
Fluorescein studies in choroidal sclerosis Am. J. Ophthalmol. 71: 266-285. 
Archer D.B., Knll A.E. and J.T. Enest (1972) 
Choroidal vascular aspects of degenerations of the retinal pigment epithelium. Trans. Ophthalmol. Soc. UK 92: 187-
207. 
AshtonN. (1953) 
Central areolar choroidal sclerosis, a hislo-palhological study. Br. J. Ophthalmol. 37: 140-147. 
Awan K.J. (1978) 
Congenital Toxoplasmosis: Changes of occurrence in subsequent siblings. Ann. Ophthalmol. 4: 456-465. 
AyaziS. (1981) 
Choroideremia, obesity, and congenital deafness. Am. J. Ophthalmol 92. 63-69. 
Baarsma G.S. and A.F. Deutman (1976) 
Serpiginous (geographic) choroiditis. Doc. Ophthalmol. 40: 269-285. 
Babel M.J. (1958) 
Lc role de la choriocapillaire dans les affections degenerative du pole posterieur. Soc Franc. Ophtalmol. 70: 389-
398. 
Barricks M.E. (1977) 
Vitelliform lesions developing in normal fundi. Am. J. Ophthalmol. 83: 324-327. 
Berson E.L., Gouras P. and R.D. Gunkel (1968) 
Progressive cone degeneration. Arch Ophthalmol. 80: 68-76. 
106 
REFERENCES 
Biesen van den P.R., Deutman A.F. and A.J.L.G. Pinckers (1985) 
Evolution of benign concentric annular macular dystrophy. Am. J. Ophthalmol. 100: 73-78. 
Blair C.J. (1975) 
Geographic atrophy of the retinal pigment epithelium. Arch. Ophthalmol. 93: 19-25. 
Bock E. (1893) 
Die angeborene Kolobome des Augenapfels. Safar, Vienna. 
Bonnet M. (1975) 
Atrophie aréolaire de la macula. Maladies de la macula, Paris pp. 266-273. 
Bonnin P., Passot M. and M.Th. Triolaire ( 1976) 
Le signe du silence choro'idien dans les dégénérescences tapéto-rétiniennes postérieures. In: De Laey, J.J. éd. 
Intemation Symposium on Fluorescein Angiography. Doc. Ophthalmol 9: 461-463 Proc. Ser. 
Brecher R. and A.C. Bird (1990) 
Adult vitteliform macular dystrophy. Eye 4: 210-215. 
Brecher R. and A.C. Bird (1990) 
Adult vitelliform dystrophy Eye 4 210-215 
Bressler N.M., Bressler S.B. and S.L. Fine ( 1988) 
Age-related macular degeneration. Surv. Ophthalmol. 32. 375-413. 
Brooser G. and Gy. Uzonyi (1968) 
Verwendung der Fluorescein-Angiographie bei der Diagnose der primaren Chorioidalklerose. 
Monatsblatter für Augenh. 152. 219-225. 
Bum R.A. (1950) 
Further cases of a fundus dystrophy with unusual features. Br. J. Ophthalmol. 34: 393-403. 
Capon M.R.C., Polinkhome P.J., Filzke F.W. and A.C. Bird (1988) 
Sorsby's pseudoinflammatory macular dystrophy - Sorsby's fundus dystrophy. Eye 2: 114-122. 
Capon M.R.C., Marshall J , Krafft J.I., Alexander R.A., Hiscott P.S. and A.C. Bird (1989) 
Sorsby's fundus dystrophy. A light and electron microscopic study. Ophthalmology 96: 1769-1777. 
Car A. (1925) 
Microzephalie und beiderseitiges Kolobom im Bereiche der Makula. Zeitschrift Augenheilk. 57: 618-627. 
CarrR.E. (1965a) 
Central areolar choroidal dystrophy. Arch. Ophthalmol. 73: 32-35. 
CarrR.E. (1965b) 
Fundus flavimaculalus. Arch. Ophthalmol. 74: 163-165. 
Carr R.E., Mittl R.N. and K.G. Noble (1975) 
Choroidal abiotrophies. Transac. Am. Ophthalmol. 79: 796-816. 
107 
Cibis G W , Morey M. and D.J. Harris (1980) 
Dominantly inherited macular dystrophy with flecks (Stargardt). Arch. Ophthalmol. 98. 1785-1789. 
Chisholm I.H., Gass J.D.M. and W.L Hutton (1976) 
The late stage of serpiginous (geographic) choroiditis. Am. J. Ophthalmol. 82: 343-351. 
Clarke E. (1927) 
Coloboma at the macula Br J. Ophthalmol. 11: 97-99. 
Clausen N.1.(1921) 
Typisches beiderseitiges hereditäres Makula-Kolobom. Klin. МЫ. Augenheilk. 67: 116. 
Collins F.C. (1992) 
Positional cloning: Let's not call it reverse anymore. Nature genetics Vol. 1 pp. 3-6. 
Coppeto J. and S Ayazi ( 1982) 
Annular macular dystrophy. Am. J. Ophthalmol. 93. 279-284. 
Cross H.E. and L.B. Bard (1974) 
Electro-oculography in Best's macular dystrophy. Am. J. Ophthalmol. 77: 46-50. 
Curry H.F. and S.S. Schonberg (1969) 
Fluorescein photography in choroidal sclerosis. Arch. Ophthalmol. 81: 177-183. 
Haas de H.L. (1931) 
Een familie met erfelijke ontaarding van de macula lutea. Ned. T. Geneesk. 75: 4720-4721. 
Deutman A.F. (1969) 
Electrooculography in families with vitelliform dystrophy of the fovea. Arch. Ophthalmol. 81: 305-316. 
Deutman A.F. (1971) 
The hereditary dystrophies of the posterior pole of the eye. Springfield, Charles C. Thomas pp. 409-425. 
Deutman A.F. ( 1974) 
Benigne concentric annular macular dystrophy. Am. J. Ophthalmol. 78: 384-396. 
Deutman A.F. and F. Lion (1977) 
Choriocapillaris nonperfusion in acute multifocal placoid pigment epilheliopathy. Am. J. Ophthalmol. 84: 652-
657. 
Deutman A.F. (1989) 
Macular dystrophies. In. Ryan S.J. (ed) Retina, volume two. Mosby co. pp 243-298. 
Douglas A.A., Wahecd I. and CT. Wyse (1968) 
Progressive bifocal chorio-retinal atrophy. Br J. Ophthalmol. 52. 742-751. 
Eagle R.C., LucierC.A., Bernardino Jr V.B. and M. Yanoff (1980) 
Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology 87 1189-1200. 
Ferry A.P., Llovera I. and D.M. Shafer (1972) 
Central areolar chonodal dystrophy. Arch. Ophthalmol. 88: 39-43 
108 
R E F E R E N C E S 
Fetkenhour CL., Gumey N.. Dobbie J.G. and E. Chromonokos ( 1976) 
Central areolar pigment epithelial dystrophy. Am. J. Ophthalmol. 81: 745-752. 
Fish C G r e y R., Sehmi K.S. and A.C. Bird (1981) 
The dark choroid in posterior retinal dystrophies. Br. J. Ophthalmol. 65: 359-363. 
FishmanG.A. (1976) 
Fundus Flavimaculatus A clinical classification. Arch. Ophthalmol. 94: 2061-2067 
Forsman K., Graff C, Nordstrom S., Johansson K., Westermark E., Lundgren E., Gustavson Κ.Η., Wadelius С. 
and G. Holmgren (1992) 
The gene for Best's macular dystrophy is located at 1 Iq 13 in a swedisch family Clin. Genet. 42: 156-159. 
Foxman S.C., Heckenlively J.R., Bateman J.B. and J.D. Wirtschafter (1985) 
Classification of congenital and early onset retinitis pigmentosa. Arch. Ophthalmol. 103: 1502-1506. 
Franceschetti Α., François J. and J. Babel (1963a) 
Les hérédo-dégénérescences choriorétiniennes. Paris, Masson et Cíe. Vol.11 627-646. 
Franceschetti A. (1963b) 
Ueber tapeto-retinale Degenerationen im Kindesalter, in Entwicklung und Fortschritt in der Augenheilkunde. 
Stuttgart, Ferdinand Enke Verlag. 
Franceschetti A. and J. François (1965a) 
Fundus Flavimaculatus. Arch. Ophtalmol (Paris) 25: 505-530. 
Franceschetti A. (1965b) 
A special form of tapeto-retinal degeneration. Fundus flavimaculatus. Trans. Am. Acad. Ophthalmol. Otolaryng. 
69: 1048-1053. 
François J., Verriest G., de Rouck A. and M. Humbelt (1956) 
Dégénérescence maculaire juvénile avec atteinte prédominante de la vision pholoplique. Ophlhalmologica 131: 
393-402. 
François J., Vemest G., de Rouck A. and D. Femandez-Sasso (1969) 
Electroretinography and electrooculography in diseases of the posterior pole. Adv. Ophthalmol. 21:132-163. 
François J. (1974) 
L'hérédité des dégénérescenses maculaires. Ophlhalmologica 168: 417-445. 
François J., De Rouck Α., Vemest G., De Laey J.J. and E. Cambie (1974) 
Progressive generalized cone dysfunction. Ophlhalmologica 169: 255-284. 
Frangieh G.T., Green W.R. and S.L. Fine (1982) 
Histopathologic study of Best's macular dystrophy. Arch. Ophthalmol. 100: 1115-1119. 
Frank H.R., Landers M.B., Williams R.J. and J.B. Sidbury (1974) 
A new dominant progressive foveal dystrophy. Am. J. Ophthalmol. 78: 903-916. 
Fraser H.B. and D.C. Wallace (1971) 
Sorsby's familial pseudo-inflammatory macular dystrophy. Am. J. Ophthalmol. 71. 1216-1220. 
109 
Freedman J and G.M. Gombos ( 1971 ) 
Bilateral macular coloboma, keratoconus and retinitis pigmentosa. Ann. Ophthalmol. 3: 664-668. 
Fuñada M., Okamoto I. and S. Hayasaka ( 1989) 
Bilateral macular coloboma associated with progresive atrophy of the peripheral retina. Ophlhalmologica 198: 8-
12. 
GassJ.D.M. (1972) 
Drusen and disciform macular detachment and degeneration. Trans. Am. Ophthalmol. Soc. 70. 409-436. 
GassJ.D.M. (1973) 
Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 90: 206-217. 
GassJ.D.M. (1974) 
A clinicopathologic study of a peculiar foveo-macular dystrophy. Trans. Am. Ophthalmol. Soc. 72: 139-156. 
GassJ.DM (1987) 
Stereoscopic atlas of macular diseases. Mosby & Co. 
Geltzcr A.I. and E.L. Berson (1969) 
Fluorescein angiography of hereditary retinal degenerations. Arch. Ophthalmol. 81: 776-782. 
Gesell A. and E.M. Blake (1936) 
Twinning and ocular pathology with a report of bilateral macular coloboma in monozygotic twins. Arch. 
Ophthalmol. 15: 1050-1071. 
Gil-Gilbemau J., Galan Α., Callis L. and C. Rodrigo (1982) 
Infantile idiopathic hypercalciuria, high congenital myopia, and atypical macular coloboma: a new oculo-renal 
syndrom'' J. Ped. Ophthalmol, and Strab. 19: 7-11. 
Godei V , Chaîne G., Regenbogen L. and G. Coscas (1986) 
Best's vitelliform macular dystrophy. Acta Ophlhalmologica 175 suppl. 1-31. 
Goodman G., Ripps H. and I.M. Siegel (1963) 
Cone dysfunction syndromes Arch. Ophthalmol. 70: 214-231 
Gouras P., Eggers H.M. and C.J. MacKay (1983) 
Cone dystrophy, nyctalopia and supernormal rod responses. Arch. Ophthalmol. 101: 718-724. 
Grey R.H.B., Blach R.K. and W.M. Barnard (1977) 
Bull's eye maculopathy with early cone degeneration. Br. J. Ophthalmol. 61: 702-718. 
Hamilton A.M. and A.C. Bird (1974) 
Geographical choroidopathy. Br. J. Ophthalmol. 58: 784-797. 
Hamilton W.K., Ewing C.C., Ives E.J. and J.D. Carruthers (1989) 
Sorsby's fundus dystrophy. Ophthalmology 96: 1755-1762. 
Hansen E., Froyshov Larsen I. and K. Berg (1976) 
A familial syndrome of progressive cone dystrophy, degenerative liver disease, endocrine dysfunction and hearing 
defects. Acta Ophthalmol. 54. 129-144. 
110 
REFERENCES 
Hardy RA and H Schatz (1987) 
Macular geographic helicoid choroidopathy Am J Ophthalmol 105 1237 1242 
Heckenlivily J R , Garcia A , Maumenee I H and J Shahinian (1979) 
Two retinitis pigmentosa (RP) syndromes RP and peripheral retinal angiomala, and RP and macular colobomata 
Invest Ophthalmol Vis Sci (ARVO suppl ) abslr 3,119 
Heckenhvely J R and R G Weleber (1986) 
X-hnked cone dystrophy with tapetal-like sheen Arch Ophthalmol 104 1322-1328 
Heckenhvely J R , Foxman S G , and Ε S Parelhoff E S (1988) 
Retinal dystrophy and macular coloboma Doc Ophthalmol 68 257-271 
Heckenhvely J R (1988) 
In Retinitis Pigmentosa J В Lippincott Co , Philadelphia pp 14-24 
HermsenVM and G F Jurdisch (1984) 
Central areolar pigment epithelial dystrophy Ophthalmologica 189 69-72 
HollowayTW (1914) 
Atrophy of the choroid with extensive sclerosis of the choroidal vessels Trans Coll Phys Philadelphia 36 316-
317 
Hoskin A , Sehmi К and А С Bird (1981) 
Sorsby's pseudoinflammatory macular dystrophy Br J Ophthalmol 65 859-856 
Howard G M and E Wolf E (1964) 
Central choroidal sclerosis A clinical and pathological study Trans Amer Acad Ophthalmol Otolaryng 68 647-
660 
Hoyng С В , Pinckers A and A F Deutman ( 1990) 
Early findings in central areolar choroidal dystrophy Acta Ophthalmol 68 356-360 
Hoyng С В , Pinckers A and Deutman A F (1992) 
Juvenile atrophy of pigment epithelium and chonocapillaris Graefe's Arch Clin Exp Ophthalmol 230 230-232 
HutterH andR Marquardt (1989) 
Zentrale areolaere Aderhaut Dystrophie Klin МЫ Augenheilk 195 177-180 
Hyvarinen 1 , Maumenee E , George Τ and G W Weinstein (1969) 
Fluorescein angiography of the chonocapillaris Am J Ophthalmol 67 653-667 
Irvine AR and FI Wergeland (1972) 
Stargardt's hereditary progressive macular degeneration Br J Ophthalmol 56 817-835 
Jamason Evans Ρ (1937) 
Familial macular coloboma Br J Ophthalmol 21 503-505 
Jacobson D M , Thompson HS and J A Bartley (1989) 
X-linked progressive cone dystrophy Ophthalmology 96 885-895 
111 
Jaeger von E. (1855) 
Beitrage zur Pathologie des Auges. 
Jampol L.M., Orth D., Daily M.J and M F. Rabb (1979) 
Subretinal neovasculansation with geographic (serpiginous) choroiditis. Am. J. Ophthalmol. 88: 683-689. 
Kaesmann В., Blankenagel A. and W. Daus (1992) 
Die zentrale areolare Pigmentepitheldyslrophie. Ophthalmologe 89: 60-66. 
Kahn H.A. and H.B. Moorhead (1973) 
Satisfies on blindness in the model reporting areas 1969-1970. United States department of Health, Education and 
Welfare Publication No (NIH) 73-427. Washington DC, US Goverment Printing Office. 
Kaplan J., Gerber S., Larget-Piet D., Rozet J.M., Dollfus H., Duller J.L. Odent-Postel-Vinay Α., Janin N. and 
M.L. Briard (1993) 
A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1. Nat. Genet. 5(3): 
308-311 
KlienB.A. (1950) 
The heredodegeneration of the macula lutea. Am. J. Ophthalmol. 33: 373-379 
KhenB.A. (1964) 
Some aspects of classification of differential diagnosis of senile macular degeneration. Am. J. Ophthalmol. 58: 
927-939 
Khen B.A. and A.E. Krill (1967) 
Fundus flavimaculatus: Clinical, functional and histopathological observations. Am. J. Ophthalmol. 64: 3-23. 
Kraushar M.F., Margohs S., Morse Ρ Η. and M.E. Nugent (1982) 
Pseudohypopyon in Best's vitelliform macular dystrophy. Am. J. Ophthalmol. 94: 30-37. 
Krill A.E. (1966) 
The electrorelinographic and electrooculographic findings in patients with macular lesions. 
Trans. Amer. Acad. Ophthalmol, and Otolarynl. 70: 1063-1083. 
Krill A E., Newell F.W. and M.I. Chishti (1968) 
Fluorescein studies in diseases affecting the retinal pigment epithelium. Am. J. Ophthalmol. 66: 470-484. 
Krill A.E. and A.F. Deutman (1972a) 
Dominant macular degenerations; the cone dystrophies. Am. J. Ophthalmol. 73: 352-369. 
Krill A.E. and A.F. Deutman (1972b) 
The various categories of juvenile macular degeneration. Trans. Am. Ophthalmol. Soc. 70: 220-245. 
Krill Α.E., Deutman A.F. and M. Fishman (1973) 
The cone degenerations Documenta ophthalmologica 35: 1-80. 
Knll A.E. (1977) 
Hereditary retinal and choroidal diseases. Vol. II. Harper and Row, publishers pp. 939-961. 
112 
R E F E R E N C E S 
Laatikainen L. and H. Erkkila (1981) 
A follow-up study on serpiginous choroiditis. Acta Ophthalmol. 59: 707-718. 
Laatikainen L. and H. Erkkila (1982) 
Subretinal and disc neovascularesation in serpiginous choroiditis. Br. J. Ophthalmol. 66:326-331. 
Lambert S.R., Creig S.U. and M.H. Narahara (1987) 
Optic Nerve Hypoplasia. Survey Ophthalmol. 32(1); 1-9. 
Lefler W.H., Wadsworth J.A.C, and J.B. Sidbury (1971) 
Hereditary macular degeneration and amino-aciduria. Am. J. Ophthalmol. 71: 224-230. 
Leibowitz H., Krueger D.E., Maunder L.R. et.al. (1980) 
The Framingham Eye Study Monograph; an ophthalmological and epidemiological study of cataract, glaucoma, 
diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. 
Surv. Ophthalmol. 24 (suppl). 335-610. 
Leighton D.A. and R. Harris (1973) 
Retinal aplasis in association with macular coloboma, keratoconus and cataract. Clin. Genet. 4: 270-274. 
Leveille A.S., Morse P.H. and J.P. Kieman (1982) 
Autosomal dominant central pigment epithelial and choroidal degeneration. Ophthalmology 89: 1407-1413. 
LevingsonG. (1899) 
Ueber Sklerose der Aderhaut mit secundarer Netzhautdegeneration. Arch. f. Augenheilk. 38: 268-273. 
Lisch W., Weidle E.G , Richard G. und H. Thiel (1989) 
Multiple vitelliforme Netzhautzysten. Klin. Mbl. Augenheilk. 194: 120-128. 
Maloney W.F., Robertson D.M. and S.M. Duboff (1977) 
Hereditary vitelliform macular degeneration. Arch. Ophthalmol. 95: 979-983. 
Mann I.C. (1927) 
On certain abnormal conditions of the macular region usually classed as colobomala. Brit. J. Ophthalmol. 11: 99-
116. 
Mann I.C. (1957) 
Developmental Abnormalities of the Eye. Philadelphia, J.B. Lippencoll Co. 
Mansour A.M. (1987) 
Central areolar choroidal dystrophy in a family with pseudochondroplastic spondyloepiphiseal dysplasia. 
Ophthal. Paed, and Gen. Vol. 9, No. I. 57-65. 
Mansour A.M., Jampol L.M., Packo K.H. and N.F. Hnsomalos (1988) 
Macular serpiginous choroiditis. Retina 8: 125-131. 
Margohs S., Scher B.M. and R.E. Carr(1977) 
Macular colobomata in Leber's congenital amaurosis. Am. J. Ophthalmol. 83: 27-31. 
113 
Маете M. and E Магте(1986) 
Erworbene Slocrungen des Farbsehens. Diagnostik. Abhandlungen Augenheilk. Band 50. 
Masi R.J., O'Connor G R. and S.J. Kimura (1978) 
Anterior uveitis in geographic or serpiginous choroiditis. Am. J. Ophthalmol. 86. 228-232. 
Maumenee A.E. (1968) 
Fluorescein angiography in the diagnosis and treatment of lesions of the ocular fundus. Trans. Ophthal. Soc. UK 
88: 529-556. 
Meier W., Blumberg Α., Imahom W., de Luca F., Wildenberg Η. and О. Oetliker ( 1979) 
Idiopathic hypercalciuria with macular colobomala. a new variant of oculo-renal syndrome. Helv. Paediat. Acta 
34: 257-269. 
Meire F.M., Bergen A.A., de Rouck Α., Leys M. and J.W. Delleman (1994) 
X-linked progressive cone dystrophy. Localisation of the gene locus to Xp21-pl 1.1 by linkage analysis. 
В J. Ophthalmol. 78 103-108. 
Menn S. and J. Landau (1970) 
Abnormal findings in relatives of patients with juvenile hereditary macular degeneration (Stargardt's disease). 
Ophthalmologica 161. 1-10. 
Miller S.A., Bresnick G.H. and S.R. Chandra (1976) 
Choroidal neovascular membrane in Best's vitelliform macular dystrophy. Am. J. Ophthalmol. 82: 252-255. 
Miller S.A. (1977) 
Multifocal Best's vitelliform dystrophy. Arch. Ophthalmol. 95: 984-990. 
Miller S.A. and G. Bresnick (1978) 
Familial bilateral macular colobomata. Br. J. Ophthalmol. 62: 261-264. 
Mohler CM. and S.L. Fine ( 1981 ) 
Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology 88: 688-692. 
Moloney L.B.M., Mooney D.J. and M.A. O'Connor (1983) 
Retinal function in Stargardt's disease and fundus flavimaculatus. Am. J. Ophthalmol. 96: 57-65. 
Moore A.T., Taylor D.S. and A. Harden (1985) 
Bilateral macular dysplasia ('colobomata') and congenital retinal dystrophy. Br. J. Ophthalmol. 69: 691-699. 
Murayama K. and E. Adachi-Usami (1989) 
Bilateral macular colobomas in Leber's congenital amaurosis. Doc. Ophthalmol. 72' 181-188. 
NettleshipE. (1884) 
Central senile areolar choroidal atrophy. Trans. Ophthal. Soc. UK 4: 165-166. 
Noble K.G. (1977) 
Central areolar choroidal dystrophy. Am. J. Ophthalmol. 84: 310-318. 
Noble G.N., Carr R.E. and I.M. Siegel ( 1977) 
Fluorescein angiography of the hereditary choroidal dystrophies. Br. J. Ophthalmol. 61: 43-53. 
114 
R E F E R E N C E S 
Noble K.G., Scher B.M. and R.E. Carr (1978) 
Polymorphous presentations m vitelliform macular dystrophy, subretinal neovasculansation and central choroidal 
atrophy. Br. J. Ophthalmol. 62: 561-570. 
Noble K.G. and R.E. Carr ( 1979) 
Stargardt's disease and fundus flavimaculatus. Arch. Ophthalmol. 97: 1281 -1285. 
Notting J.G.A. and A.J.L.G. Pinckers (1978) 
Diagnostic problems in Stargardt's macular dystrophy and fundus flavimaculatus. Docum. Ophthalmol. Proc. Ser. 
17:307-312. 
Novotny H.R. and D.L. Alvis (1961) 
A method of photographing fluorescence in circulating blood in the human retina. Circulation 24: 82-86 
O'Gorman S., Flaherty W.A., Fishman G.A. and E.L. Berson (1988) 
Histopathologic findings in Best's vitelliform macular dystrophy. Arch. Ophthalmol. 106. 1261-1268. 
Pasman F.M H. and A. Pinckers (1982) 
Hereditary macular coloboma. Ophthal. Paed, and Gen. 2:1 67-72 
Pearlman J.T., Owen W.G and D.W. Brounley (1974) 
Cone dystrophy with dominant inheritance Am. J. Ophthalmol. 77: 293-303. 
Phillips C.I. and D.L. Griffiths (1969) 
Macular coloboma and skeletal abnormality. Br. J. Ophthalmol. 53: 346-349. 
Phillips C.I. (1970) 
Hereditary macular coloboma. J. Med. Gen. 7: 224-226. 
Phillips C.I., Stokoe I. and M. Newton (1981 ) 
Congenital macular 'coloboma' and retinal aplasia. Acta ophthalmol. 59; 894-900. 
Pinckers A.J.L.G. (1971) 
La maladie de Stargardt. Ann. Oculist. 204: 1331-1346. 
Pinckers A.J.L.G. (1971) 
Verworven stoornissen van de kleurzin. Thesis, Nijmegen. 
Pinckers A.J.L.G. (1980) 
Colour vision and age. Ophthalmologe 181: 23-30. 
Pinckers A.J.L.G. and R.M. Broekhuyse (1983) 
The EOG in rheumatoid arthritis Acta Ophthalmol. 61: 831-837. 
Pinckers A.J.L.G. (1984a) 
Clinical colour vision examination. Doc. Ophthalmol. Proc. Series 38. 171-179. 
Pinckers A.J.L.G. and G. Vemest (1984b) 
Results of a shortened lightness discrimination test. Bull. Soc. Beige Ophthalmol. 210: 149-153. 
115 
Pinckers A.J.L.G., Nabbe В. and H. Vossen (1985) 
Standard Pseudoisochromatic Plates. Ophthalmologica 190: 218-224. 
Pinckers A.J.L.G. and A.F. Deutman (1987) 
X-hnked cone dystrophy, an overlooked diagnosis 7 . Int. Ophthalmol. 10: 241-243. 
Polkinghome P.J., Capon M.R.C., BemingerT , Lyness A.L., Sehmi K. and A С Bird (1989) 
Sorsby's fundus dystrophy. Ophthalmology 96. 1763-1769. 
Regenbogen L.S. and G.J. Coscas (1985) 
Oculo-auditory syndromes. Masson Publishing USA, Inc. 
RetzeW. (1902) 
Einige interessante Spiegelfálle. Deutschmann's Beitr. zur Augenheilk. 5: 94-107. 
SandvigK. (1955) 
Familiar central areolar choroidal atrophy of autosomal dominant inheritance. Acta Ophthalmol. 37 71 -78. 
SandvigK. (1959) 
Central areolar choroidal atrophy. Acta Ophthalmol. 37: 325-329. 
SarksS.H and J.P. Sarks( 1989) 
Age-related macular degeneration, atrophic form. In: Ryan, S.J. (ed) Retina, volume two. Mosby co.pp 149-173. 
Satorre J., Lopez J.M., Martinez J. and P. Pinera (1990) 
Dominant macular colobomata. J. Ped Ophthalmol. Strab. 27: 148-152. 
Schatz H., Maumenee Α.E. and A. Patz (1974) 
Geographic hehcoid peripapillary choroipopalhy. a clinical presentation and fluorescein angiographic findings. 
Trans. Am. Acad. Ophthalmol. Otolaryng. 78 747-761. 
Schott К. (1921) 
Ueberdas sogenannte Kolobom der Makula. Klin. Monatsbl. Augenheilk. 67: 415-424. 
Secchi A.G., Tognon M.S. and С Maselli (1990) 
Cyclosporine-A in the treatment of serpiginous choroiditis. Int. Ophthalmol. 14: 395-399. 
Small K.W. (1989) 
North Carolina macular dystrophy. Ophthalmology 96: 1747-1754. 
Small K.W., Kilhan J. and W.C. McLean (1991) 
North Carolina's dominant progressive macular dystrophy: how progressive is it?. Br. J. Ophthalmol. 75: 401-406. 
Small K.W., Hermsen V , Gumey N.. Fetkenhour C.L. and J С Folk (1992a) 
North Carolina macular dystrophy and central areolar pigment epithelial dystrophy. Arch. Ophthalmol. 110: 515-
518. 
Small K.W., Weber J.L., Roses Α., Lennon F., Vance J.M. and M.A Pericak-Vance (1992b) 
North Carolina macular dystrophy is assigned to chromosome 6. Genomics 13. 681-685. 
116 
R E F E R E N C E S 
Sorsby A (1935) 
Choroidal sclerosis Proc Royal Soc Med 28 526-528 
Sorsby A (1935) 
Congenital coloboma of the macula, together with an account of the familial occurence of bilateral macular 
coloboma in association with apical dystrophy of hands and feet Br J Ophthalmol 19 65-87 
Sorsby A (1939) 
Chonodal angio-sclerosis with special reference to its hereditary character Br J Ophthal 23 433-444 
Sorsby A , Mason Μ E J and N Gardener ( 1949) 
A fundus dystrophy with unusual features Br J Ophthalmol 33 67-97 
Sorsby A (1951) 
Genetics in Ophthalmology Butterworth, London pp 148-158 
Sorsby A and R Ρ Crick (1953) 
Central areolar sclerosis Br J Ophthalmol 37 129-139 
Sorsby A (1972) 
The incidences and causes of blindness in England and Wales 1963-1968, Ministry of Health Reports on Public 
Health and Medical Subjects, No 128 London, Her Majesty's Stationary Office 
Stanford Morton, A (1885) 
Atrophy of choroid Trans Ophthal Soc UK 5 142-144 
StankovicMI (1958) 
L'angiosclerose choroidienne familiale liée au sexe Bull Soc France Ophthalmol 17 411-419 
StargardtK (1909) 
Ueber familiare progressive degeneration in der Makulagegend des Auges Graefes Arch Klin Ophthalmol 71 
534-550 
Steinmetz R L , Gamer A , Maguire J I and A С Bird (1991) 
Histopathology of incipient fundus flavimaculatus Ophthalmology 98 953-956 
Stem G A and Ρ E Romano (1978) 
Congenital Ocular Toxoplasmosis Arch Ophthalmol 96 615-617 
TakkiK (1974) 
Differential diagnosis between the primary total choroidal atrophies Br J Ophthalmol 58 24-35 
Tamaki S , Garcia С A and J Katzmann (1979) 
Macular coloboma Invest Ophthalmol Vis Sci (Arvo suppl ) abstr 15,222 
Thijssen J M , Pinckers A J L G and A J Otto ( 1974) 
A multipurpose optical system for ophthalmic electrodiagnosis Ophthalmologica 168 308-314 
Thompson A H (1905) 
Central senile choroiditis Trans Ophthal Soc UK 25 118-120 
117 
Verdoom С. and A. Pinckers (1988) 
X-linked cone dystrophy. Doc. Ophthalmologica 70: 195-198. 
Vine A.K. and H. Schatz (1980) 
Adult-onset foveomacular pigment epithelial dystrophy. Am. J. Ophthalmol. 89: 680-691. 
Waardenburg P.J.. Franceschetli A, and D. Klein (1961) 
Genetics and Ophthalmology. Van Gorcum, Assen pp. 787-795. 
Waardenburg P.J. (1938) 
Einige Beobachtungen bei erblichen Augenabweichungen. Klin. Monatsbl. Augenh. 101:924-925. 
Waardenburg P.J. (1952) 
Angio-sclérose familiale de la choroïde. J. Genet. Hum. 1: 83-93. 
Waardenburg P.J. (1963) 
Genetics and Ophthalmology. Vol. I, Blackwell, Oxford. 
Weingeist T.A., Kobrin J.L. and R.C. Walzke (1982) 
Histopathology of Best's vitelliform macular dystrophy. Arch. Ophthalmol. 100: 1108-1121. 
Weise E.E and L.A. Yannuzzi ( 1974) 
Ring maculopathies mimicking chloroquine retinopathy. Am. J. Ophthalmol. 78: 204-208. 
Weiss H., Annesly Jr W.H., Shields J.A., Toner T. and K. Chnslopherson (1979) 
The clinical course of serpiginous choroidopathy. Am. J. Ophthalmol. 87: 133-142. 
Wroblewski J.J., Weiss III J.A., Eckstein Α., Fitzke F., Jubb В., Keen J., Ingleheam C, Bhattacharya S., Arden 
G.B., Jay M. and A.C. Bird (1994) 
Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. 
Ophthalmology 101: 12-22 
Wu J., Lewis H., Fine S.L., Grover D.A. and W.R. Green (1989) 
Clinicopathological findings in a patient with serpiginous choroiditis and treated choroidal neovascularisation. 
Retina 9: 292-301 
Zhang K., Bilher P.P., Park R., Donoso L.A., Seidman J.G. and CE. Seidman (1994) 
A dominant Stargardl's macular dystrophy locus maps to chromosome 13q34. 
Arch. Ophthalmol. 112: 759-764. 
Zrenner E., Nowicki J. and R. Adamczyk (1986) 
Cone function and cone interaction in hereditary degenerations of the central retina. Doc. Ophthalmol. 62: 5-12. 
118 
Summary 
Central areolar choroidal dystrophy (CACD) is a hereditary disease which leads 
to a circumscript atrophy of neuroretina, pigment epithelium, choriocapillaris and 
the smaller choroidal vessels in the posterior pole of the eye of middle-aged 
patients. 
In this thesis, the development and genetic aspects of the disorder is described 
in thirty affected individuals from seven families with affected siblings in two or 
more generations, as well as in seven sporadic cases, on the basis of clinical, 
functional and electro-physiological findings. CACD is furthermore differentiated 
from other ocular disorders that may cause a similar atrophy in the posterior pole. 
Most cases in literature in which the clinical picture of CACD has been 
described, or in which specific angiographic, (electro-)physiological or 
clinicopathological findings have been reported, have been advanced cases of 
CACD. Only a few early cases of CACD have been mentioned but even these 
patients had already shown some loss of vision. 
On the basis of ophthalmoscopic and angiographic changes described by 
various authors, the development of CACD is divided into 4 stages: Stage I 
consists of slight parafoveal pigmentary changes; stage II shows more severe 
alterations of the pigment epithelium, encompassing the intact fovea for more than 
180 degrees; in stage III one sees, in addition to the above mentioned changes, 
atrophy of the choriocapillaris; stage IV is similar to stage III but the fovea is also 
involved. 
In seventy-four eyes of thirty familial and seven sporadic cases, eight eyes with 
stage I, thirteen eyes with stage II, twenty-nine eyes with stage III and twenty-four 
eyes with stage IV CACD were encountered. Most patients exhibiting stage I or II 
of the disease, were younger than forty years of age and had no visual complaints, 
while almost all patients suffering from stage III or IV of the disease, were older 
than forty years of age and experienced visual disturbances. There was no sex 
predilection. 
Although most fundus lesions could be observed fundoscopically, fluorescein 
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angiography was a great help in detecting some of the earlier pigmentary changes 
which were difficult to visualize. In a number of patients suffering from stage III 
CACD, fluorescein angiography showed more choriocapillaris atrophy than was 
apparent during ophthalmoscopy. In approximately half of the cases of CACD, the 
photopic ERG was found to be subnormal while the scotopic ERG and the EOG 
were mostly normal. Colour vision testing showed no abnormalities, diminished 
red sensitivity or a blue-yellow defect in stages I or II of the disease. In stage III, a 
combined red-green and blue-yellow defect was often encountered, indicating that 
the fovea itself had already become affected to some extent. Visual field tests 
revealed a decreased parafoveal sensitivity in stages I and II and a decreased 
central sensitivity in stage III. On the basis of the findings in this study, the 
classification of the disease into stages was expanded as follows: 
stage I: ages twenty to forty; visual acuity is normal; parafoveal pigmentary 
changes may be found in fundoscopy, but are evident in fluorescein angiography; 
ERG and EOG are normal; diminished red sensitivity with pseudoprotanomaly and 
decreased parafoveal sensitivity may be found in colour vision and visual field 
tests; 
stage II: ages twenty to fifty; sometimes visual complaints occur; parafoveal 
hypopigmentation evident in fundoscopy; mottled hyperfluorescence in fluorescein 
angiography; photopic ERG may be subnormal; colour vision and visual fields as 
in stage I; 
stage III: most patients are older than forty years of age; visual acuity is 
moderately reduced; parafoveal atrophy of the pigment epithelium occurs; atrophy 
of the choriocapillaris not seen in fundoscopy, may be evident in fluorescein 
angiography; ERG, dark adaptation and EOG may be subnormal; a blue-yellow 
defect is often accompanied by a red-green colour vision defect; parafoveal and 
foveal reduced sensitivity demonstrated in visual field tests; 
stage IV: ages forty to seventy; visual acuity generally below О.1.; demarcated 
central area of atrophy of pigment epithelium and choriocapillaris in fundoscopy 
and fluorescein angiography; ERG, dark adaptation as in stage III; combined blue-
yellow and red-green colour vision defect; central scotoma in visual field tests. 
Age-related macular degeneration, Stargardt's disease, juvenile atrophy of the 
retinal pigment epithelium and choriocapillaris, central areolar epithelial dystrophy, 
progressive cone dystrophy, vitelliform dystrophies, serpiginous choroiditis, 
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macular colobomata, Sorsby's fundus dystrophy, North Carolina macular dystrophy 
and benign concentric annular macular dystrophy are all diseases of the posterior 
pole that may give rise to a morphological lesion, more or less resembling CACD. 
However, by carefully comparing the genetic nature, age of onset of visual 
complaints, the degree of visual loss, the fundoscopic and angiographic picture and 
the outcome of the various (electro-)physiological tests, it is deemed possible to 
differentiate these entities effectively from CACD. 
In two cases, CACD was found together with the development of perceptive 
hearing loss. This combination has not yet been described in literature and may be 
a special clinical entity. 
Familial cases were shown to be autosomal-dominantly inherited, with complete 
penetrance over the age of 50. X-linked heredity was not found. Age-related 
penetrance in the age group between twenty and forty was 50%. Apparent sporadic 
cases may be recessively inherited. In future, these families could very well be 
used in order to localize the gene or genes causing this disease. 
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Samenvatting 
Centrale areolaire chorioidea dystrofie (CACD) is een erfelijke ziekte, die bij 
patiënten van middelbare leeftijd uiteindelijk tot een duidelijk omschreven atrofie 
van de zenuwvezellaag en het pigmentblad van de retina, de choriocapillaris en de 
kleine chorioidale vaten in de achterpool van het oog leidt. 
In dit proefschrift wordt aan de hand van klinische, functionele en 
(electro)fysiologische gegevens, die wij vonden bij dertig familieleden (uit totaal 
zeven families, waarin de ziekte in twee of meer generaties voorkomt) en bij zeven 
sporadische gevallen de ontwikkeling en de genetische aspecten van dit ziekte-
beeld beschreven. Daarnaast wordt CACD gedifferentieerd van andere ziekte-
beelden, die tot een soortgelijke atrofie van de achterpool kunnen leiden. 
De in de literatuur beschreven gevallen van CACD, waarbij het klinisch beeld, 
de specifieke angiografische, electro- fysiologische of de histopathologische 
aspecten van dit ziektebeeld beschreven worden, betreft het meestal zeer ver 
gevorderde stadia van de atrofie. Slechts enkele gevallen van deze ziekte met een 
vroeger stadium zijn beschreven. Bij deze gevallen was echter al sprake van enig 
visusverlies. 
Aan de hand van de ophthalmoscopische en angiografische bevindingen van 
verschillende auteurs verdeelden wij de ontwikkeling van CACD in vier stadia: 
stadium I vertoont kleine parafoveale pigmentbladophelderingen; stadium II laat 
meer uitgebreide atrofie van het pigmentblad zien; bij stadium III is er naast 
bovengenoemde veranderingen ook atrofie van de choriocapillaris aanwezig; bij 
stadium IV is ook de fovea hierin betrokken. 
Van de vierenzeventig ogen van dertig familieleden en zeven sporadische 
gevallen werden er acht in stadium I, dertien in stadium II, negenentwintig in 
stadium III en vierentwintig in stadium IV ingedeeld. De meeste patiënten uit de 
stadia I en II waren jonger dan veertig jaar en hadden over het algemeen geen 
visusklachten terwijl de meeste patiënten in stadium III en IV ouder dan veertig 
jaar waren en wel visusklachten hadden. De verdeling over beide geslachten was 
gelijk. 
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De meeste fundusafwijkingen konden met behulp van fundoscopie gedetecteerd 
worden, maar fluorescentie-angiografie was erg zinvol om met name bij zeer 
vroege stadia de aanwezigheid van pigmentbladveranderingen te bevestigen. Bij 
een aantal patiënten met CACD stadium III toonde fluorescentie-angiografie meer 
atrofie van de choriocapillaris aan dan aanvankelijk met fundoscopie kon worden 
gezien. Bij ongeveer de helft van het aantal gevallen met CACD werd een 
subnormaal photopisch ERG gevonden terwijl het scotopisch ERG en het EOG 
meestal normaal waren. Het kleurenzien vertoonde in de eerste twee stadia ofwel 
geen afwijkingen of een verlaagde roodgevoeligheid of een blauw-geel defect. Een 
gecombineerd blauw-geel en rood-groen defect wees er in het stadium III op dat de 
fovea ook al enigszins was aangetast. Gezichtsveldonderzoek liet een verlaagde 
parafoveale gevoeligheid in stadium I en II en een verlaagde foveale gevoeligheid 
in stadium II zien. Aan de hand van de bevindingen van deze studie werd de 
classificatie van deze ziekte als volgt uitgebreid: 
Stadium I: tussen de twintig en veertig jaar; normale visus; parafoveale 
pigmentbladveranderingen, die bij oogspiegelen soms te zien zijn, zijn met 
fluorescentie angiografie waarneembaar; het ERG en EOG zijn normaal; verlaagde 
roodgevoeligheid met pseudoprotanomalie en verlaagde parafoveale gevoeligheid 
bij respectievelijk kleurenzien en perimetric 
Stadium II: tussen de twintig en vijftig jaar; soms visusklachten; parafoveale 
hypopigmentaties fundoscopisch goed te zien; mottige hyperfluorescentie bij 
fluorescentie-angiografie; photopisch ERG soms subnormaal; kleurenzien en 
Perimetrie als in stadium I. 
Stadium III: meeste patiënten ouder dan veertig jaar; visus meestal matig aangetast; 
duidelijke parafoveale atrofie van het pigmentepitheel; atrofie van de 
choriocapillris niet altijd te zien bij oogspiegelen maar wel bij fluorescentie 
angiografie; ERG, donkeradaptatie en EOG soms subnormaal; een blauw-geel 
defect gaat vaak samen met een rood-groen defect; perimetric laat foveale en 
parafoveale verlaagde gevoeligheid zien. 
Stadium IV: van veertig to zeventig jaar; visus meestal lager dan 0.1; duidelijk 
afgegrensd gebied in de achterpool waarbinnen atrofie van het pigmentblad en de 
choriocapillaris te zien zijn bij fundoscopie en fluorescentie-angiografie; ERG en 
donkeradaptatie als stadium III; gecombineerd blauw-geel en rood-groen 
kleurenzienstoomis; centraal scotoom bij Perimetrie. 
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Leeftijdgebonden maculadegeneratie, de ziekte van Stargardt, de juveniele atrofie 
van het retinale pigmentblad en choriocapillaris, de centrale areolaire 
pigmentbladdystrofie, de progressieve kegeldystrofie, de colobomen van de 
macula, de fundus dystrofie van Sorsby, de North Carolina maculadystrofie en de 
benigne concentrische annulaire dystrofie kunnen allemaal een laesie in de 
achterpool veroorzaken, die uiterlijk op CACD lijken. Door echter aandachtig de 
aard van de overerving, de leeftijd waarop de visusklachten beginnen, de mate van 
visusverlies, het fundoscopisch en angiografisch beeld alsmede de uitslagen van de 
verschillende (electro)fysiologische testen met elkaar te vergelijken, is het goed 
mogelijk om de verschillende ziekte-beelden te onderscheiden. 
Bij twee patiënten werd CACD samen met perceptie-doofheid gevonden. Deze 
combinatie werd niet eerder in de literatuur beschreven. Mogelijkerwijs gaat het 
hierbij om een nieuw ziekte-beeld. 
Bij de families in dit proefschrift hadden we te maken met een autosomaal 
dominante overerving met volledige penetrance boven de vijftig jaar. De 
leeftijdgebonden penetrantie in de leeftijdgroep tussen de twintig en veertig jaar 
was 50%. Bij de sporadische gevallen is er mogelijk sprake van autosomaal 
recessieve overerving. In de toekomst zal met behulp van familieleden uit deze 
families verder onderzoek gedaan kunnen worden om uiteindelijk het gen of de 
genen op te sporen die aanleiding geven tot dit ziekte-beeld. 
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STELLINGEN 
Behorende bij het proefschrift 
CENTRAL AREOLAR 
CHOROIDAL DYSTROPHY 
its natural course, genetic aspects 
and differential diagnosis 
door 
Carel Benedict Hoyng 
Nijmegen, 30 november 1994 
Bij de centrale areolaire chorioidea dystrofie gaan afwijkingen van het kleurenzien 
en het gezichtsveld vooraf aan het visusverlies. 
Bij het onderzoek naar het voorkomen de centrale areolaire chorioidea dystrofie bij 
jonge patiënten is een goed fluorescentie angiogram onmisbaar. 
Onderzoek van het kleurenzien is onmisbaar bij de detectie en discriminatie van 
maculadystrofieën. 
De juveniele atrofie van het retinale pigmentblad en de choriocapillaris is een 
nieuw oogheelkundig ziekte-beeld. 
Oogchirurgie is de meest kritieke van alle takken van chirurgie, 
(in 'Ophthalmic operations'Philps R., p.l) 
Opereren is vooruitzien. 
Bij de constructie van de hoofdsteun van de spleetlamp voor oogheelkundig 
onderzoek is geen rekening gehouden met de variatie in borstomvang van het 
menselijk lichaam. 
De grote drang van de Nederlanders naar nivellering heeft ertoe geleid dat 
Nederland de laatste honderd jaar nauwelijks iets heeft kunnen bijdragen aan de 
internationale culturele ontwikkeling. 
Genetisch onderzoek zal uiteindelijk de zogenaamde 'splitters' gelijk geven. 
Bij het aannemen van assistenten in opleiding mag de wetenschappelijke 
voorgeschiedenis van de kandidaat maar zeer ten dele een rol spelen. 
De 'blinde vlek' is geen vlek én is niet blind. 
Dat een vinaigrette meer olie dan azijn dient te bevatten moet als een culinaire 
misvatting gezien worden. 
Als de ogen op elkaar gericht zijn, kunnen de neuzen niet dezelfde kant op staan. 


